wkwkwkwk的个人主页 - 老虎社区

wkwkwkwk

暂无个人介绍

IP属地：未知

5关注

1粉丝

0主题

0勋章

2021-09-01

Will more companies continue to hold virtual meeting?

ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today

2021-09-01

Please help to like

抱歉，原内容已删除

2021-08-28

Anyoneb uying?

Which Biotech Stock Will Shock the Market in 2022?

2021-08-28

Great news

抱歉，原内容已删除

2021-08-27

Interesting. Please help to like too

抱歉，原内容已删除

2021-08-25

Go go go

抱歉，原内容已删除

2021-08-25

Like

Here's Why Visa Is One of the Best Long-Term Stocks to Buy

2021-08-24

Please help to like

抱歉，原内容已删除

2021-08-22

Great news. Please help to like

抱歉，原内容已删除

2021-08-14

Will take a look

2 Tech Stocks With 96% to 140% Upside, According to Wall Street

2021-08-14

Good job!

Microsoft Could Be A Buy For Its Upcoming Dividend

2021-08-11

Go apple go

抱歉，原内容已删除

2021-08-11

Nice

Here's Who's Making a $1 Billion Bet on Moderna

2021-08-11

Great

Novavax shares jumped nearly 12% in early trading.

2021-06-23

Good. Please help comment.tks.

These ‘quality’ global stocks look cheap, says Morgan Stanley

2021-06-23

Good. Keep it up

抱歉，原内容已删除

2021-06-17

Can be online store

Do Netflix's Retail Ambitions Make Any Sense?

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582032677933516","uuid":"3582032677933516","gmtCreate":1618941710686,"gmtModify":1618941710686,"name":"wkwkwkwk","pinyin":"wkwkwkwk","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":818440405,"gmtCreate":1630435416807,"gmtModify":1633678108868,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Will more companies continue to hold virtual meeting?","listText":"Will more companies continue to hold virtual meeting?","text":"Will more companies continue to hold virtual meeting?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/818440405","repostId":"1155259610","repostType":4,"repost":{"id":"1155259610","kind":"news","pubTimestamp":1630421174,"share":"https://www.laohu8.com/m/news/1155259610?lang=&edition=full","pubTime":"2021-08-31 22:46","market":"us","language":"en","title":"ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1155259610","media":"investorplace","summary":"Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of t","content":"<p><b>Zoom Video Communications</b>(NASDAQ:<b><u>ZM</u></b>) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.</p>\n<p>Let’s dive into that earnings report below to see what has ZM stock falling today.</p>\n<ul>\n <li>The biggest problem facing Zoom Video this morning is its guidance for the upcoming quarter.</li>\n <li>That begins with an outlook for Q3 that includes&nbsp;adjusted earnings per share of $1.07 to $1.08.</li>\n <li>This would have it missing Wall Street’s estimate of $1.09 for the quarter.</li>\n <li>There’s also the fact that Zoom Video is seeing slower growth now that lockdowns are coming to an end.</li>\n <li>That’s a result of schools and businesses using the company’s services less and less to hold virtual meetings.</li>\n <li>These are pulling down an otherwise solid earnings report for the company.</li>\n <li>Its adjusted earnings per share for the current quarter was $1.36, which beat out Wall Street’s estimate of $1.16.</li>\n <li>Revenue of $1.02 billion was also better than the $990.96 million that analysts were expecting.</li>\n</ul>\n<p>Eric Yuan, founder and CEO of Zoom Video, said the following in the earnings report affecting ZM stock today.</p>\n<blockquote>\n “In Q2, we achieved our first billion dollar revenue quarter while delivering strong profitability and cash flow. Q2 also marked several milestones on our expansion beyond the UC platform. We launched Zoom Apps, bringing over 50 apps directly into the Zoom experience, and Zoom Events, an all-in-one digital events service.”\n</blockquote>\n<p>It’s also worth pointing out that ZM stock is seeing heavy trading alongside this news. As of this writing, more than 15 million shares of the stock have changed hands. That’s a significant increase over its daily average trading volume of about 3.2 million shares.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.\nLet’s dive into that earnings ...</p>\n\n<a href=\"https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"source_url":"https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155259610","content_text":"Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.\nLet’s dive into that earnings report below to see what has ZM stock falling today.\n\nThe biggest problem facing Zoom Video this morning is its guidance for the upcoming quarter.\nThat begins with an outlook for Q3 that includes adjusted earnings per share of $1.07 to $1.08.\nThis would have it missing Wall Street’s estimate of $1.09 for the quarter.\nThere’s also the fact that Zoom Video is seeing slower growth now that lockdowns are coming to an end.\nThat’s a result of schools and businesses using the company’s services less and less to hold virtual meetings.\nThese are pulling down an otherwise solid earnings report for the company.\nIts adjusted earnings per share for the current quarter was $1.36, which beat out Wall Street’s estimate of $1.16.\nRevenue of $1.02 billion was also better than the $990.96 million that analysts were expecting.\n\nEric Yuan, founder and CEO of Zoom Video, said the following in the earnings report affecting ZM stock today.\n\n “In Q2, we achieved our first billion dollar revenue quarter while delivering strong profitability and cash flow. Q2 also marked several milestones on our expansion beyond the UC platform. We launched Zoom Apps, bringing over 50 apps directly into the Zoom experience, and Zoom Events, an all-in-one digital events service.”\n\nIt’s also worth pointing out that ZM stock is seeing heavy trading alongside this news. As of this writing, more than 15 million shares of the stock have changed hands. That’s a significant increase over its daily average trading volume of about 3.2 million shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818440623,"gmtCreate":1630435284462,"gmtModify":1633678109093,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/818440623","repostId":"1173998132","repostType":4,"isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819489817,"gmtCreate":1630087728639,"gmtModify":1704955826188,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Anyoneb uying?","listText":"Anyoneb uying?","text":"Anyoneb uying?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819489817","repostId":"2162602132","repostType":4,"repost":{"id":"2162602132","kind":"highlight","pubTimestamp":1630076857,"share":"https://www.laohu8.com/m/news/2162602132?lang=&edition=full","pubTime":"2021-08-27 23:07","market":"us","language":"en","title":"Which Biotech Stock Will Shock the Market in 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=2162602132","media":"Motley Fool","summary":"Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?","content":"<p>In 2019, tiny&nbsp;<b><a href=\"https://laohu8.com/S/AXSM\">Axsome Therapeutics</a>&nbsp;</b>(NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech,&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a>&nbsp;</b>(NASDAQ:NVAX), came out of nowhere to stomp the stock market, with its share price skyrocketing by 2,700%. For most of 2021, yet another small biotech has been the top-performing stock in the market, as&nbsp;<b><a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a> </b>(NASDAQ:SAVA) jumped from under $7 a share in January to $123 a share on Aug. 24. (Whether it will keep its lead is another question, as the volatility is savage -- the stock is down to $52 as of Friday morning after news of a citizen petition against the company.)</p>\n<p>What's fascinating about the biotech sector in particular is how fast it moves. The sector is notorious for amazing price swings -- in either direction -- that can happen overnight. So why is that? Why are biotech stocks in particular so volatile? Why do they keep leading the market every year? And what biotech stock might -- repeat, <i>might&nbsp;</i>-- pull off this feat next year? Let's analyze why Axsome, Novavax, and Cassava zoomed higher over the last few years, and why I think <b><a href=\"https://laohu8.com/S/PIRS\">Pieris Pharmaceuticals</a> </b>(NASDAQ:PIRS) has a chance at a similar remarkable performance in 2022.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F638648%2Fgettyimages-108224060.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"465\" referrerpolicy=\"no-referrer\"></p>\n<h2>Biotech winners tend to start off tiny</h2>\n<p>The main reason these stocks were able to soar so impressively is that all three started with very tiny market caps. At the end of 2018, Axsome Therapeutics had a micro-cap valuation of $85 million. In 2019, Novavax stock fell to below $1, and the company had to do a 1-for-20 reverse split in order to keep its shares listed on the <b><a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a></b>. And at the beginning of 2020, Cassava had barely achieved small-cap status, with its market cap hovering at $240 million.</p>\n<p>So all three barn-burning stocks started off unloved by the market. Why does a biotech stock get so cheap? Probably the most common reason is the market believes the company's science is bad. Novavax, for instance, had a notable failure in its quest for a respiratory syncytial virus (RSV) vaccine. This clinical trial failure sent investors to the exits and sent the stock down into a crater in 2019, when it plunged to $4 a share (or $0.20 pre-split).</p>\n<p>Yet the market was spectacularly wrong about Novavax. While the company's RSV drug was a failure, Novavax had another drug in clinical trials, a flu vaccine. And this drug was a world-beater. It was flying through clinical trials, and it had defeated the market-leading flu vaccines from <b><a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a></b>&nbsp;(NASDAQ:SNY) over and over again.</p>\n<p>In 2019, Novavax had the label of \"bad science,\" but the data for a different drug said otherwise. Sometimes companies with tiny market caps actually have compelling drugs that are performing exceptionally well in clinical trials. If you find such a company, you might want to buy some shares.</p>\n<h2>Is there enough money for a phase 3 trial?</h2>\n<p>That said, it's not enough just to have good science. Nobody is allowed to market their drugs to the public until that science has been validated in clinical trials and approved by the U.S. Food and Drug Administration -- and clinical trials cost a huge amount of money. Thus, before investing, it's important to determine whether the biotech has enough cash for a phase 3 trial. If the answer is \"no,\" the drug is stalled and won't go anywhere.</p>\n<p>Many unprofitable biotech companies finesse the money issue by collaborating with Big Pharma. When you see such a collaboration, you can have faith that there's enough cash for a phase 3 trial. However, these arrangements also often mean that the bigger pharmaceutical company acquires the rights to the molecule. And that can be like like selling off your future in order to pay the bills today.</p>\n<p>Interestingly, neither Axsome nor Novavax nor Cassava have an active collaboration with any big-pharma leaders. Instead, all three of these companies have elected to own 100% of the rights to their lead molecules. While the median expense for a phase 3 trial is $19 million, the numbers can vary dramatically, depending on how large the patient population is. I'd be nervous if a biotech had less than $100 million in cash (each of these has more). There's no question this independent approach is riskier, but also potentially a lot more rewarding.</p>\n<p>Biotech investors often like to see collaboration with Big Pharma -- it's a validation of the science, and it removes a lot of financial worries for small companies. But if you're chasing big rewards, you might want to look at biotech companies that are still independent (and have enough cash to stay that way).</p>\n<h2>Can Pieris pull off a miracle run in 2022?</h2>\n<p>Pieris stock is very cheap right now, with a $291 million valuation. (You know a stock is cheap when it could have a 10-bagger and still qualify as a small-cap!) Is the stock so cheap because its science is bad?</p>\n<p>It would probably be more accurate to say that Pieris' science is unproven. Like many unprofitable biotechs, Pieris doesn't have a drug in phase 3 trials yet. In fact, we're still waiting on positive phase 2 data. So it's early, and that's a danger sign. The reason Axsome, Novavax, and Cassava all skyrocketed is that all three companies made the journey from unproven drug to pivotal trials very quickly. Pieris is a few years away.</p>\n<p>Another major difference is that Pieris has signed multiple collaborative deals -- with <b>Roche</b>, <b>AstraZeneca</b>, and <b>Seagen</b>, among others. In <a href=\"https://laohu8.com/S/AONE.U\">one</a> sense that's good news, because it means that money for clinical trials isn't an issue for the company. Any drugs that work will make it to phase 3 trials and beyond. And all this collaboration adds confidence that the company is on the right track.</p>\n<p>Is Pieris sacrificing its future to pay for its present? In my opinion, no. While AstraZeneca now has rights to the company's asthma drug (its lead molecule), what makes Pieris such an exciting stock is not <a href=\"https://laohu8.com/S/AONE.U\">one</a> particular drug, but the company's entire platform. Pieris owns the rights to all the Anticalin proteins, and its library contains more than 100 billion of these new molecules. Anticalins are much smaller than antibodies, and as such can go where antibodies cannot. AstraZeneca paid big bucks for the rights to Pieris' asthma drug because that Anticalin molecule is small enough to go directly to the lung.</p>\n<p>I love the risk/reward equation for Pieris. If the company's drugs actually work -- we'll have data in that regard next year -- the stock will shoot much higher. Under its existing collaboration agreements, Pieris might make up to $9 billion if its Anticalin drugs reach certain milestones.&nbsp;But what will really make the stock take off is if/when other pharmaceutical players start making deals to add some of the company's Anticalin molecules to their pipelines.</p>\n<p>How do you value an entire new class of pharmaceuticals? Well, in 2019, worldwide sales for monoclonal antibodies (mAbs) totaled <i>$163 billion</i>. If Pieris' partners report any positive data on its Anticalin drugs next year, the upside for this stock is enormous.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Which Biotech Stock Will Shock the Market in 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhich Biotech Stock Will Shock the Market in 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In 2019, tiny Axsome Therapeutics (NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXSM":"Axsome Therapeutics, Inc.","NVAX":"诺瓦瓦克斯医药","SAVA":"Cassava Sciences Inc"},"source_url":"https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162602132","content_text":"In 2019, tiny Axsome Therapeutics (NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech, Novavax (NASDAQ:NVAX), came out of nowhere to stomp the stock market, with its share price skyrocketing by 2,700%. For most of 2021, yet another small biotech has been the top-performing stock in the market, as Cassava Sciences Inc (NASDAQ:SAVA) jumped from under $7 a share in January to $123 a share on Aug. 24. (Whether it will keep its lead is another question, as the volatility is savage -- the stock is down to $52 as of Friday morning after news of a citizen petition against the company.)\nWhat's fascinating about the biotech sector in particular is how fast it moves. The sector is notorious for amazing price swings -- in either direction -- that can happen overnight. So why is that? Why are biotech stocks in particular so volatile? Why do they keep leading the market every year? And what biotech stock might -- repeat, might -- pull off this feat next year? Let's analyze why Axsome, Novavax, and Cassava zoomed higher over the last few years, and why I think Pieris Pharmaceuticals (NASDAQ:PIRS) has a chance at a similar remarkable performance in 2022.\n\nBiotech winners tend to start off tiny\nThe main reason these stocks were able to soar so impressively is that all three started with very tiny market caps. At the end of 2018, Axsome Therapeutics had a micro-cap valuation of $85 million. In 2019, Novavax stock fell to below $1, and the company had to do a 1-for-20 reverse split in order to keep its shares listed on the Nasdaq. And at the beginning of 2020, Cassava had barely achieved small-cap status, with its market cap hovering at $240 million.\nSo all three barn-burning stocks started off unloved by the market. Why does a biotech stock get so cheap? Probably the most common reason is the market believes the company's science is bad. Novavax, for instance, had a notable failure in its quest for a respiratory syncytial virus (RSV) vaccine. This clinical trial failure sent investors to the exits and sent the stock down into a crater in 2019, when it plunged to $4 a share (or $0.20 pre-split).\nYet the market was spectacularly wrong about Novavax. While the company's RSV drug was a failure, Novavax had another drug in clinical trials, a flu vaccine. And this drug was a world-beater. It was flying through clinical trials, and it had defeated the market-leading flu vaccines from Sanofi SA (NASDAQ:SNY) over and over again.\nIn 2019, Novavax had the label of \"bad science,\" but the data for a different drug said otherwise. Sometimes companies with tiny market caps actually have compelling drugs that are performing exceptionally well in clinical trials. If you find such a company, you might want to buy some shares.\nIs there enough money for a phase 3 trial?\nThat said, it's not enough just to have good science. Nobody is allowed to market their drugs to the public until that science has been validated in clinical trials and approved by the U.S. Food and Drug Administration -- and clinical trials cost a huge amount of money. Thus, before investing, it's important to determine whether the biotech has enough cash for a phase 3 trial. If the answer is \"no,\" the drug is stalled and won't go anywhere.\nMany unprofitable biotech companies finesse the money issue by collaborating with Big Pharma. When you see such a collaboration, you can have faith that there's enough cash for a phase 3 trial. However, these arrangements also often mean that the bigger pharmaceutical company acquires the rights to the molecule. And that can be like like selling off your future in order to pay the bills today.\nInterestingly, neither Axsome nor Novavax nor Cassava have an active collaboration with any big-pharma leaders. Instead, all three of these companies have elected to own 100% of the rights to their lead molecules. While the median expense for a phase 3 trial is $19 million, the numbers can vary dramatically, depending on how large the patient population is. I'd be nervous if a biotech had less than $100 million in cash (each of these has more). There's no question this independent approach is riskier, but also potentially a lot more rewarding.\nBiotech investors often like to see collaboration with Big Pharma -- it's a validation of the science, and it removes a lot of financial worries for small companies. But if you're chasing big rewards, you might want to look at biotech companies that are still independent (and have enough cash to stay that way).\nCan Pieris pull off a miracle run in 2022?\nPieris stock is very cheap right now, with a $291 million valuation. (You know a stock is cheap when it could have a 10-bagger and still qualify as a small-cap!) Is the stock so cheap because its science is bad?\nIt would probably be more accurate to say that Pieris' science is unproven. Like many unprofitable biotechs, Pieris doesn't have a drug in phase 3 trials yet. In fact, we're still waiting on positive phase 2 data. So it's early, and that's a danger sign. The reason Axsome, Novavax, and Cassava all skyrocketed is that all three companies made the journey from unproven drug to pivotal trials very quickly. Pieris is a few years away.\nAnother major difference is that Pieris has signed multiple collaborative deals -- with Roche, AstraZeneca, and Seagen, among others. In one sense that's good news, because it means that money for clinical trials isn't an issue for the company. Any drugs that work will make it to phase 3 trials and beyond. And all this collaboration adds confidence that the company is on the right track.\nIs Pieris sacrificing its future to pay for its present? In my opinion, no. While AstraZeneca now has rights to the company's asthma drug (its lead molecule), what makes Pieris such an exciting stock is not one particular drug, but the company's entire platform. Pieris owns the rights to all the Anticalin proteins, and its library contains more than 100 billion of these new molecules. Anticalins are much smaller than antibodies, and as such can go where antibodies cannot. AstraZeneca paid big bucks for the rights to Pieris' asthma drug because that Anticalin molecule is small enough to go directly to the lung.\nI love the risk/reward equation for Pieris. If the company's drugs actually work -- we'll have data in that regard next year -- the stock will shoot much higher. Under its existing collaboration agreements, Pieris might make up to $9 billion if its Anticalin drugs reach certain milestones. But what will really make the stock take off is if/when other pharmaceutical players start making deals to add some of the company's Anticalin molecules to their pipelines.\nHow do you value an entire new class of pharmaceuticals? Well, in 2019, worldwide sales for monoclonal antibodies (mAbs) totaled $163 billion. If Pieris' partners report any positive data on its Anticalin drugs next year, the upside for this stock is enormous.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819480291,"gmtCreate":1630087550113,"gmtModify":1704955825153,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Great news","listText":"Great news","text":"Great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819480291","repostId":"1123342356","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810476834,"gmtCreate":1629999498828,"gmtModify":1704954431941,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Interesting. Please help to like too","listText":"Interesting. Please help to like too","text":"Interesting. Please help to like too","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810476834","repostId":"2162018921","repostType":4,"isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834706889,"gmtCreate":1629826611441,"gmtModify":1633682165778,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/834706889","repostId":"1118949007","repostType":4,"isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834701017,"gmtCreate":1629826015139,"gmtModify":1633682167032,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/834701017","repostId":"2161818081","repostType":4,"repost":{"id":"2161818081","kind":"highlight","pubTimestamp":1629819036,"share":"https://www.laohu8.com/m/news/2161818081?lang=&edition=full","pubTime":"2021-08-24 23:30","market":"us","language":"en","title":"Here's Why Visa Is One of the Best Long-Term Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2161818081","media":"Motley Fool","summary":"The largest payments network is still growing.","content":"<p>If you're like millions of people, you've already used your <b><a href=\"https://laohu8.com/S/V\">Visa</a></b>&nbsp;(NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.</p>\n<p>The payment network took a big hit during the early stages of the pandemic, when consumer spending plunged. But it's rebounding along with the economy, and that's where its strength lies. As the largest credit card network in the world, it makes money whenever you swipe your card, making this blue-chip company a surefire bet for long-term growth.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F636551%2Fgettyimages-1331306883.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Powering payments</h2>\n<p>Visa's network facilitates payments from consumers to merchants and takes a small fee from each transaction. The sheer number of people who use Visa credit cards demonstrates the company's dominance in the market -- there are currently 3.6 billion Visa cards in use, which translates into almost half the world's population. In 2019, Visa processed more than 200 billion transactions, or more than $11 trillion in volume.</p>\n<p>Because Visa's model is a platform, it's a high-margin business that easily turns sales into profits. Operating margin was over 66% in Q3, and Visa turned $6.1 billion in revenue into $2.6 billion in net income. It also produced more than $4 billion in free cash flow, which it uses to grow its business as well as pay dividends and repurchase stock.</p>\n<p>Business plummeted during the height of pandemic restrictions, but the recovery is moving along. Revenue for the company's fiscal third quarter, covering the period ended June 30, increased 27% from the same period in 2020, but&nbsp; 10% over pre-pandemic 2019 levels.</p>\n<p>Because the pandemic was such an outlier, we can see Visa's strength more clearly in its long-term growth. As of the latest quarter, Visa has grown revenue by a 9.5%&nbsp;compound annual growth rate (CAGR) over the past five years, and net income by an even better rate of 14.3%.</p>\n<h2>Fintech revolution</h2>\n<p>One of the ways Visa is protecting its top spot in credit card processing is acquiring and making deals with fintech partners. Its proposed acquisition of Plaid, a private company that connects financial apps with institutions, was scrapped after it was given a no-go by regulators. But it's made many smaller acquisitions to grow its business and especially to stay relevant as digital payments become more important. Most recently, it acquired Currencycloud, an app that simplifies foreign exchange to make cross-border payments easier. In Q3, it also announced that it would acquire Tink, a Swedish-based open banking platform.</p>\n<p>Visa needs to upgrade its systems as companies like <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b>&nbsp;make it easier to send and spend money digitally. Contactless payments are increasing in popularity, and in the U.S. alone Visa customers have more than 370 million tap-to-pay cards. Installment plans have also taken off, with companies such as <b>Afterpay</b>&nbsp;(recently acquired by <b>Square</b>) and <b>Affirm Holdings</b>&nbsp;demonstrating strong growth, and Visa has launched its own version as well.</p>\n<h2>Rewarding investors</h2>\n<p>At Monday's prices, Visa's stock has gained roughly 190% over the past five years, almost double the <b>S&amp;P 500</b> index. While it's trailing the broader market over the past year, it's still up nearly 15% as it's dealt with the weight of the pandemic. Its dividend yields 0.55% at the current price, well below the S&amp;P 500 average, but the company has raised its payout annually since 2008.</p>\n<p>Since it generally mirrors the state of the economy, which an overwhelming amount of the time expands rather than contracts, Visa is great long-term stock to own. Its top position makes it hard to compete with, and it can provide security and stability to a balanced portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Visa Is One of the Best Long-Term Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Visa Is One of the Best Long-Term Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're like millions of people, you've already used your Visa (NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.\nThe payment network took...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa"},"source_url":"https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161818081","content_text":"If you're like millions of people, you've already used your Visa (NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.\nThe payment network took a big hit during the early stages of the pandemic, when consumer spending plunged. But it's rebounding along with the economy, and that's where its strength lies. As the largest credit card network in the world, it makes money whenever you swipe your card, making this blue-chip company a surefire bet for long-term growth.\nImage source: Getty Images.\nPowering payments\nVisa's network facilitates payments from consumers to merchants and takes a small fee from each transaction. The sheer number of people who use Visa credit cards demonstrates the company's dominance in the market -- there are currently 3.6 billion Visa cards in use, which translates into almost half the world's population. In 2019, Visa processed more than 200 billion transactions, or more than $11 trillion in volume.\nBecause Visa's model is a platform, it's a high-margin business that easily turns sales into profits. Operating margin was over 66% in Q3, and Visa turned $6.1 billion in revenue into $2.6 billion in net income. It also produced more than $4 billion in free cash flow, which it uses to grow its business as well as pay dividends and repurchase stock.\nBusiness plummeted during the height of pandemic restrictions, but the recovery is moving along. Revenue for the company's fiscal third quarter, covering the period ended June 30, increased 27% from the same period in 2020, but  10% over pre-pandemic 2019 levels.\nBecause the pandemic was such an outlier, we can see Visa's strength more clearly in its long-term growth. As of the latest quarter, Visa has grown revenue by a 9.5% compound annual growth rate (CAGR) over the past five years, and net income by an even better rate of 14.3%.\nFintech revolution\nOne of the ways Visa is protecting its top spot in credit card processing is acquiring and making deals with fintech partners. Its proposed acquisition of Plaid, a private company that connects financial apps with institutions, was scrapped after it was given a no-go by regulators. But it's made many smaller acquisitions to grow its business and especially to stay relevant as digital payments become more important. Most recently, it acquired Currencycloud, an app that simplifies foreign exchange to make cross-border payments easier. In Q3, it also announced that it would acquire Tink, a Swedish-based open banking platform.\nVisa needs to upgrade its systems as companies like PayPal Holdings make it easier to send and spend money digitally. Contactless payments are increasing in popularity, and in the U.S. alone Visa customers have more than 370 million tap-to-pay cards. Installment plans have also taken off, with companies such as Afterpay (recently acquired by Square) and Affirm Holdings demonstrating strong growth, and Visa has launched its own version as well.\nRewarding investors\nAt Monday's prices, Visa's stock has gained roughly 190% over the past five years, almost double the S&P 500 index. While it's trailing the broader market over the past year, it's still up nearly 15% as it's dealt with the weight of the pandemic. Its dividend yields 0.55% at the current price, well below the S&P 500 average, but the company has raised its payout annually since 2008.\nSince it generally mirrors the state of the economy, which an overwhelming amount of the time expands rather than contracts, Visa is great long-term stock to own. Its top position makes it hard to compete with, and it can provide security and stability to a balanced portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835470370,"gmtCreate":1629735942190,"gmtModify":1633682812558,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/835470370","repostId":"1198789813","repostType":4,"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832955495,"gmtCreate":1629567875117,"gmtModify":1633684015904,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Great news. Please help to like","listText":"Great news. Please help to like","text":"Great news. Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/832955495","repostId":"2161745179","repostType":4,"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897333477,"gmtCreate":1628877095199,"gmtModify":1633688806393,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Will take a look","listText":"Will take a look","text":"Will take a look","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897333477","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","kind":"highlight","pubTimestamp":1628864400,"share":"https://www.laohu8.com/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for&nbsp;<b>Coinbase Global</b> (NASDAQ:COIN) and&nbsp;<b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range&nbsp;of products to 68 million&nbsp;users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2%&nbsp;of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson&nbsp;value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees&nbsp;comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price&nbsp;of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2020 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Monthly transacting users</p></td>\n   <td width=\"156\"><p>1.5 million</p></td>\n   <td width=\"156\"><p>8.8 million</p></td>\n   <td width=\"156\"><p>487%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$633.8 million</p></td>\n   <td width=\"156\"><p>$4.9 billion</p></td>\n   <td width=\"156\"><p>678%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase&nbsp;SEC filings. TTM&nbsp;= trailing-12-months. CAGR&nbsp;= compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built&nbsp;to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler&nbsp;value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Customers</p></td>\n   <td width=\"156\"><p>442,752</p></td>\n   <td width=\"156\"><p>1.2 million</p></td>\n   <td width=\"156\"><p>65%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Gross profit</p></td>\n   <td width=\"156\"><p>$5.7 million</p></td>\n   <td width=\"156\"><p>$26.5 million</p></td>\n   <td width=\"156\"><p>116%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc.","COIN":"Coinbase Global, Inc."},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1},"isVote":1,"tweetType":1,"viewCount":205,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897333828,"gmtCreate":1628877032664,"gmtModify":1633688806840,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Good job!","listText":"Good job!","text":"Good job!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897333828","repostId":"2159821885","repostType":4,"repost":{"id":"2159821885","kind":"news","pubTimestamp":1628865635,"share":"https://www.laohu8.com/m/news/2159821885?lang=&edition=full","pubTime":"2021-08-13 22:40","market":"us","language":"en","title":"Microsoft Could Be A Buy For Its Upcoming Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2159821885","media":"Simply Wall St.","summary":"Microsoft Corporation (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend d","content":"<p><b>Microsoft Corporation</b> (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend date is <a href=\"https://laohu8.com/S/AONE.U\">one</a> business day before the record date, which is the cut-off date for shareholders to be present on the company's books to be eligible for a dividend payment. It is important to be aware of the ex-dividend date because any trade on the stock needs to have been settled on or before the record date. Therefore, if you purchase Microsoft's shares on or after the 18th of August, you won't be eligible to receive the dividend, when it is paid on the 9th of September.</p>\n<p>The company's next dividend payment will be US$0.56 per share, and in the last 12 months, the company paid a total of US$2.24 per share. Calculating the last year's worth of payments shows that Microsoft has a trailing yield of 0.8% on the current share price of $289.81. If you buy this business for its dividend, you should have an idea of whether Microsoft's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.</p>\n<p>Check out our latest analysis for Microsoft</p>\n<p>Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Microsoft paid out a comfortable 28% of its profit last year. A useful secondary check can be to evaluate whether Microsoft generated enough free cash flow to afford its dividend. It distributed 29% of its free cash flow as dividends, a comfortable payout level for most companies.</p>\n<p>It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.</p>\n<p>Click here to see the company's payout ratio, plus analyst estimates of its future dividends.</p>\n<p class=\"t-img-caption\"><img src=\"https://s.yimg.com/uu/api/res/1.2/BdBRcdx9GWAsYwcOGwlNPA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/879002c79492bbd3bb1260ed6a40a52f\" tg-width=\"821\" tg-height=\"508\" width=\"100%\" height=\"auto\"><span>NasdaqGS:MSFT Historic Dividend August 13th 2021</span></p>\n<h3>Have Earnings And Dividends Been Growing?</h3>\n<p>Companies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If earnings fall far enough, the company could be forced to cut its dividend. It's encouraging to see Microsoft has grown its earnings rapidly, up 26% a year for the past five years. Microsoft is paying out less than half its earnings and cash flow, while simultaneously growing earnings per share at a rapid clip. Companies with growing earnings and low payout ratios are often the best long-term dividend stocks, as the company can both grow its earnings and increase the percentage of earnings that it pays out, essentially multiplying the dividend.</p>\n<p>The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Microsoft has increased its dividend at approximately 13% a year on average. It's exciting to see that both earnings and dividends per share have grown rapidly over the past few years.</p>\n<h3>The Bottom Line</h3>\n<p>Has Microsoft got what it takes to maintain its dividend payments? We love that Microsoft is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. These characteristics suggest the company is reinvesting in growing its business, while the conservative payout ratio also implies a reduced risk of the dividend being cut in the future. It's a promising combination that should mark this company worthy of closer attention.</p>\n<p>While it's tempting to invest in Microsoft for the dividends alone, you should always be mindful of the risks involved. For example - Microsoft has <b>1 warning sign</b> we think you should be aware of.</p>\n<p>A common investment mistake is buying the first interesting stock you see. Here you can find a list of promising dividend stocks with a greater than 2% yield and an upcoming dividend.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft Could Be A Buy For Its Upcoming Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft Could Be A Buy For Its Upcoming Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/microsoft-nasdaq-msft-could-buy-085435825.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Microsoft Corporation (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be ...</p>\n\n<a href=\"https://finance.yahoo.com/news/microsoft-nasdaq-msft-could-buy-085435825.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"source_url":"https://finance.yahoo.com/news/microsoft-nasdaq-msft-could-buy-085435825.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2159821885","content_text":"Microsoft Corporation (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be present on the company's books to be eligible for a dividend payment. It is important to be aware of the ex-dividend date because any trade on the stock needs to have been settled on or before the record date. Therefore, if you purchase Microsoft's shares on or after the 18th of August, you won't be eligible to receive the dividend, when it is paid on the 9th of September.\nThe company's next dividend payment will be US$0.56 per share, and in the last 12 months, the company paid a total of US$2.24 per share. Calculating the last year's worth of payments shows that Microsoft has a trailing yield of 0.8% on the current share price of $289.81. If you buy this business for its dividend, you should have an idea of whether Microsoft's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.\nCheck out our latest analysis for Microsoft\nDividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Microsoft paid out a comfortable 28% of its profit last year. A useful secondary check can be to evaluate whether Microsoft generated enough free cash flow to afford its dividend. It distributed 29% of its free cash flow as dividends, a comfortable payout level for most companies.\nIt's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.\nClick here to see the company's payout ratio, plus analyst estimates of its future dividends.\nNasdaqGS:MSFT Historic Dividend August 13th 2021\nHave Earnings And Dividends Been Growing?\nCompanies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If earnings fall far enough, the company could be forced to cut its dividend. It's encouraging to see Microsoft has grown its earnings rapidly, up 26% a year for the past five years. Microsoft is paying out less than half its earnings and cash flow, while simultaneously growing earnings per share at a rapid clip. Companies with growing earnings and low payout ratios are often the best long-term dividend stocks, as the company can both grow its earnings and increase the percentage of earnings that it pays out, essentially multiplying the dividend.\nThe main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Microsoft has increased its dividend at approximately 13% a year on average. It's exciting to see that both earnings and dividends per share have grown rapidly over the past few years.\nThe Bottom Line\nHas Microsoft got what it takes to maintain its dividend payments? We love that Microsoft is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. These characteristics suggest the company is reinvesting in growing its business, while the conservative payout ratio also implies a reduced risk of the dividend being cut in the future. It's a promising combination that should mark this company worthy of closer attention.\nWhile it's tempting to invest in Microsoft for the dividends alone, you should always be mindful of the risks involved. For example - Microsoft has 1 warning sign we think you should be aware of.\nA common investment mistake is buying the first interesting stock you see. Here you can find a list of promising dividend stocks with a greater than 2% yield and an upcoming dividend.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892048448,"gmtCreate":1628617046884,"gmtModify":1633745695180,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Go apple go","listText":"Go apple go","text":"Go apple go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/892048448","repostId":"1160585513","repostType":4,"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892048507,"gmtCreate":1628616982409,"gmtModify":1633745695303,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892048507","repostId":"2158048475","repostType":4,"repost":{"id":"2158048475","kind":"highlight","pubTimestamp":1628600160,"share":"https://www.laohu8.com/m/news/2158048475?lang=&edition=full","pubTime":"2021-08-10 20:56","market":"us","language":"en","title":"Here's Who's Making a $1 Billion Bet on Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2158048475","media":"Motley Fool","summary":"The total bet size is even higher.","content":"<p>Few stocks are as hot as&nbsp;<b>Moderna</b> (NASDAQ:MRNA) is right now. The vaccine maker's shares have soared more than 360% so far this year. And that comes on top of the 434% gain in 2020.</p>\n<p>That kind of performance tends to attract investors' attention -- and deservedly so. Some might view the vaccine stock as overpriced now that its market cap tops $190 billion. But not everyone.</p>\n<p>There's <a href=\"https://laohu8.com/S/AONE.U\">one</a> investor preparing to make a $1 billion bet on Moderna. Who is it? None other than Moderna itself.</p>\n<h2>Investing heavily</h2>\n<p>Moderna stated in its second-quarter update that its board of directors authorized a share repurchase program of up to $1 billion. Don't expect the company to spend all that money at one time, though. The authorized funds can be used over a two-year period to buy back shares.</p>\n<p>Actually, Moderna has invested and will invest a lot more than just $1 billion in its business. CFO David Meline noted in the company's Q2 conference call that Moderna more than tripled its research and development spending year over year in the first half of 2021. He said to expect significantly increased R&amp;D investments going forward.</p>\n<p>In addition, Moderna plans to make between $450 million and $550 million this year in capital investments. These investments include a major expansion of capacity to be able to manufacture up to 3 billion doses of its COVID-19 vaccine in 2022. The company is also investing in technology improvements and beefing up its global commercial operations.</p>\n<h2>Why buy back shares?</h2>\n<p>Probably the most important reason why Moderna is preparing to invest so much in itself is that the company's management team is very confident in its business prospects. CEO Stéphane Bancel said in the Q2 call, \"We are very optimistic about the future of Moderna and we are just getting started.\"</p>\n<p>Another reason why Moderna is ready to spend up to $1 billion in stock buybacks is that it's likely going to have more cash than it knows what to do with. The company ended the second quarter with a cash stockpile of $12.2 billion. That amount will almost certainly continue to grow.</p>\n<p>Moderna expects to rake in $20 billion in sales from its COVID-19 vaccine this year. It already has advance purchase agreements worth $12 billion plus another $8 billion in options for next year.</p>\n<p>Repurchasing shares is actually Moderna's third investment priority. The company first wants to reinvest in its base business, which includes the aforementioned increased R&amp;D and capital spending. Moderna also is interested in expanding its pipeline through business development, deals including licensing and acquisitions.</p>\n<p>Moderna's board seems to think that the company will still have plenty of money left over after investing in those two top priorities. Based on the company's revenue projections, it should easily be able to spare $1 billion for stock buybacks.</p>\n<h2>A good bet?</h2>\n<p>Just because Moderna <i>can</i> spend $1 billion on share repurchases doesn't mean that it <i>should</i> do so. I don't think Moderna should make that $1 billion bet in buying back shares.&nbsp;My view is that stock buybacks at Moderna's current valuation (or anywhere close to it) would be ill-advised.</p>\n<p>Of course, Moderna could wait to buy back shares only on pullbacks.&nbsp;However, unless its shares plunge significantly, I think that Moderna would better serve its shareholders by making a strategic acquisition with the $1 billion than buying its own richly priced shares.</p>\n<p>The company needs to be able to generate growth after the worst of the pandemic ends. With only one non-COVID-19 pipeline candidate soon to enter late-stage testing, buying a smaller biotech is the easiest way to achieve that growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Who's Making a $1 Billion Bet on Moderna</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Who's Making a $1 Billion Bet on Moderna\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 20:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/10/heres-whos-making-a-1-billion-bet-on-moderna/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Few stocks are as hot as Moderna (NASDAQ:MRNA) is right now. The vaccine maker's shares have soared more than 360% so far this year. And that comes on top of the 434% gain in 2020.\nThat kind of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/10/heres-whos-making-a-1-billion-bet-on-moderna/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/08/10/heres-whos-making-a-1-billion-bet-on-moderna/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158048475","content_text":"Few stocks are as hot as Moderna (NASDAQ:MRNA) is right now. The vaccine maker's shares have soared more than 360% so far this year. And that comes on top of the 434% gain in 2020.\nThat kind of performance tends to attract investors' attention -- and deservedly so. Some might view the vaccine stock as overpriced now that its market cap tops $190 billion. But not everyone.\nThere's one investor preparing to make a $1 billion bet on Moderna. Who is it? None other than Moderna itself.\nInvesting heavily\nModerna stated in its second-quarter update that its board of directors authorized a share repurchase program of up to $1 billion. Don't expect the company to spend all that money at one time, though. The authorized funds can be used over a two-year period to buy back shares.\nActually, Moderna has invested and will invest a lot more than just $1 billion in its business. CFO David Meline noted in the company's Q2 conference call that Moderna more than tripled its research and development spending year over year in the first half of 2021. He said to expect significantly increased R&D investments going forward.\nIn addition, Moderna plans to make between $450 million and $550 million this year in capital investments. These investments include a major expansion of capacity to be able to manufacture up to 3 billion doses of its COVID-19 vaccine in 2022. The company is also investing in technology improvements and beefing up its global commercial operations.\nWhy buy back shares?\nProbably the most important reason why Moderna is preparing to invest so much in itself is that the company's management team is very confident in its business prospects. CEO Stéphane Bancel said in the Q2 call, \"We are very optimistic about the future of Moderna and we are just getting started.\"\nAnother reason why Moderna is ready to spend up to $1 billion in stock buybacks is that it's likely going to have more cash than it knows what to do with. The company ended the second quarter with a cash stockpile of $12.2 billion. That amount will almost certainly continue to grow.\nModerna expects to rake in $20 billion in sales from its COVID-19 vaccine this year. It already has advance purchase agreements worth $12 billion plus another $8 billion in options for next year.\nRepurchasing shares is actually Moderna's third investment priority. The company first wants to reinvest in its base business, which includes the aforementioned increased R&D and capital spending. Moderna also is interested in expanding its pipeline through business development, deals including licensing and acquisitions.\nModerna's board seems to think that the company will still have plenty of money left over after investing in those two top priorities. Based on the company's revenue projections, it should easily be able to spare $1 billion for stock buybacks.\nA good bet?\nJust because Moderna can spend $1 billion on share repurchases doesn't mean that it should do so. I don't think Moderna should make that $1 billion bet in buying back shares. My view is that stock buybacks at Moderna's current valuation (or anywhere close to it) would be ill-advised.\nOf course, Moderna could wait to buy back shares only on pullbacks. However, unless its shares plunge significantly, I think that Moderna would better serve its shareholders by making a strategic acquisition with the $1 billion than buying its own richly priced shares.\nThe company needs to be able to generate growth after the worst of the pandemic ends. With only one non-COVID-19 pipeline candidate soon to enter late-stage testing, buying a smaller biotech is the easiest way to achieve that growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":26,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892048809,"gmtCreate":1628616876701,"gmtModify":1633745695424,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892048809","repostId":"1181860181","repostType":4,"repost":{"id":"1181860181","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628603123,"share":"https://www.laohu8.com/m/news/1181860181?lang=&edition=full","pubTime":"2021-08-10 21:45","market":"us","language":"en","title":"Novavax shares jumped nearly 12% in early trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1181860181","media":"Tiger Newspress","summary":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the th","content":"<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p>\n<p>The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p>\n<p>The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p>\n<p>Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped nearly 12% in early trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped nearly 12% in early trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-10 21:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p>\n<p>The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p>\n<p>The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p>\n<p>Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181860181","content_text":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported Barron's.\nThe pension also doubled its investment in COVID-19 vaccine play Moderna Inc .\nThe retirement fund also initiated a position in BioNTech SE , the German COVID-19 vaccine partner of Pfizer Inc.\nAlso on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.","news_type":1},"isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123545816,"gmtCreate":1624431637135,"gmtModify":1634006210755,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Good. Please help comment.tks.","listText":"Good. Please help comment.tks.","text":"Good. Please help comment.tks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/123545816","repostId":"1120218733","repostType":4,"repost":{"id":"1120218733","kind":"news","pubTimestamp":1624430778,"share":"https://www.laohu8.com/m/news/1120218733?lang=&edition=full","pubTime":"2021-06-23 14:46","market":"us","language":"en","title":"These ‘quality’ global stocks look cheap, says Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=1120218733","media":"cnbc","summary":"Analysts atMorgan Stanleyhave picked stocks that they believe are currently “cheap” and represent “q","content":"<div>\n<p>Analysts atMorgan Stanleyhave picked stocks that they believe are currently “cheap” and represent “quality at a reasonable price.”\nIn a research note titled “Any Cheap Cyclicals Left?” and focused on ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/22/investing-ideas-morgan-stanley-picks-6-cheap-stocks-to-buy.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These ‘quality’ global stocks look cheap, says Morgan Stanley</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese ‘quality’ global stocks look cheap, says Morgan Stanley\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 14:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/22/investing-ideas-morgan-stanley-picks-6-cheap-stocks-to-buy.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Analysts atMorgan Stanleyhave picked stocks that they believe are currently “cheap” and represent “quality at a reasonable price.”\nIn a research note titled “Any Cheap Cyclicals Left?” and focused on ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/22/investing-ideas-morgan-stanley-picks-6-cheap-stocks-to-buy.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"0J3F.UK":"索迪斯","SDXAY":"Sodexo","SSP":"E.W. Scripps Co Cl A"},"source_url":"https://www.cnbc.com/2021/06/22/investing-ideas-morgan-stanley-picks-6-cheap-stocks-to-buy.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1120218733","content_text":"Analysts atMorgan Stanleyhave picked stocks that they believe are currently “cheap” and represent “quality at a reasonable price.”\nIn a research note titled “Any Cheap Cyclicals Left?” and focused on the travel and leisure sector, the bank said Monday that many stocks have the economic recovery priced into their valuations. Cyclical stocks are those whose performance tends to be in line with the economy.\nBut the analysts said several picks “stand out from our screens as looking cheap.”\nThree of Morgan Stanley’s recommendations have a potential upside of at least 20% to the bank’s share price target in a best-case scenario.\nThe analysts’ 6 stock picks are:\nFrench catering and services companySodexohas a potential upside of 23%, according to Morgan Stanley, which called it a “quality operator.” It described airport foodservice firmSSPin the same way, and said the stock has a 7% potential upside. SSP stock is up 16% since the start of the year, according to the bank.\nTwo of the bank’s picks have a potential upside of 29%: British pub companyMitchells and Butlers(M&B) and gambling firmFlutter, which operates brands including PokerStars and Betfair. It picked M&B as one of the “most attractive” stocks for free cashflow yield, noting its stock price has risen 32% since the start of the year.\nBritish hotel and restaurant operatorWhitbreadis also a pick for the bank, which estimated its upside potential at 10%, and it also chose gambling operatorEvolution, with a potential upside of 21%.\n“With investors continuing to look through what has so far been a later-than-expected reopening, we revisit our screens looking at 2019 and 2023 multiples (2020-22 distorted by Covid). We conclude that a lot of the recovery looks priced in with only a handful of names looking good value,” the bank’s analysts stated.\nMorgan Stanley’s valuations are based on its forecasts for 2023, assuming a return to normality after populations have been vaccinated against Covid-19. “Our bull cases factor in scenarios for structurally higher margins and/or higher market shares post-Covid,” its analysts wrote. Morgan Stanley is overweight all of the stocks mentioned, indicating it expects them to outperform.\n“Our strategists recommend quality at a reasonable price: Our EU Strategy team believe the macro environment has become somewhat less conducive for equity markets as growth momentum starts to peak and QE tapering discussions gather pace,” the analysts wrote.QE taperingrefers to the reduction in quantitative easing put in place by central banks to stimulate economies in light of the pandemic.\n“They also recently downgraded Cyclicals after a record rally which left positioning stretched and relative valuations at or near record highs. They believe this is an increasingly micro stock picking market over the summer and now recommend a more balanced approach to style and sector selection,” the analysts added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129443536,"gmtCreate":1624383706825,"gmtModify":1634006905996,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Good. Keep it up","listText":"Good. Keep it up","text":"Good. Keep it up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129443536","repostId":"1163697674","repostType":4,"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163809865,"gmtCreate":1623865742157,"gmtModify":1634026753218,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582032677933516","authorIdStr":"3582032677933516"},"themes":[],"htmlText":"Can be online store","listText":"Can be online store","text":"Can be online store","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163809865","repostId":"2143792622","repostType":4,"repost":{"id":"2143792622","kind":"highlight","pubTimestamp":1623855000,"share":"https://www.laohu8.com/m/news/2143792622?lang=&edition=full","pubTime":"2021-06-16 22:50","market":"us","language":"en","title":"Do Netflix's Retail Ambitions Make Any Sense?","url":"https://stock-news.laohu8.com/highlight/detail?id=2143792622","media":"Motley Fool","summary":"This surprising move will initially spark comparisons to Disney and Amazon, but the company's real inspiration probably comes from China.","content":"<p><b>Netflix</b> (NASDAQ:NFLX) recently launched Netflix.shop, an online store for apparel and lifestyle products, in a surprising leap into the retail sector.</p>\n<p>Its initial products include streetwear and action figures based on the anime series <i>Yasuke</i> and <i>Eden</i>, as well as limited-edition apparel, and products inspired by <i>Lupin</i> and produced in collaboration with the Louvre. It's also selling anime-inspired collectibles from up-and-coming designers like Nathalie Nguyen, Kristopher Kites, and Jordan Bentley.</p>\n<p>Netflix.shop will also eventually sell exclusive tie-in products for popular series like <i>The Witcher</i> and <i>Stranger Things</i>, as well as Netflix-branded apparel from the Japanese fashion house BEAMS. It will initially launch the marketplace in the U.S. before expanding into other countries.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fc4c819061f1fb41dd3e6cc33a8a8ae8\" tg-width=\"700\" tg-height=\"465\"><span>Image source: Netflix.</span></p>\n<p>This doesn't represent Netflix's first attempt at selling tie-in products for its streaming franchises. <b>Target</b>, for example, already carries a wide range of <i>Yasuke</i> products. However, Netflix.shop marks Netflix's first attempt to sell all those tie-in products through its own online marketplace.</p>\n<p>Netflix.shop will spark comparisons to <b>Disney</b> (NYSE:DIS) and <b>Amazon </b>(NASDAQ:AMZN), but is it actually chasing those companies? Or should investors look overseas to understand Netflix's true goals?</p>\n<h2>Could Netflix be responding to Disney and Amazon?</h2>\n<p>Netflix's online store is much smaller than <b>Disney</b>'s (NYSE:DIS) sprawling retail business. At the end of 2020, Disney owned and operated about 200 stores across North America, 60 stores in Europe, 45 stores in Japan, and two stores in China. It also sells its products online and licenses its brands to third-party companies.</p>\n<p>Netflix competes against Disney in the streaming market, but I doubt it will follow Disney's example and open hundreds of brick-and-mortar stores, for three simple reasons.</p>\n<p>First, brick-and-mortar stores are more capital-intensive than online stores. It would be absurd for Netflix, which already plans to spend $17 billion on new streaming content this year, to set aside fresh cash for new physical stores instead of expanding its streaming library.</p>\n<p>Second, physical stores are highly exposed to online competition and the decline of offline shopping. Lastly, Netflix doesn't own as many popular franchises as Disney, which can easily fill its shelves with merchandise from its namesake properties as well as Pixar, Marvel, and Star Wars products.</p>\n<p>Netflix.shop also might seem like an attempt to counter Amazon, which leveraged the strength of its Prime e-commerce ecosystem to tether more viewers to its Prime Video service.</p>\n<p>That strategy would represent a reversal of Amazon's strategy since Netflix would be leveraging its strength in streaming video to expand into the retail market. But I also doubt Netflix plans to pour billions of dollars into challenging Amazon in the cutthroat e-commerce market.</p>\n<h2>So what's Netflix's game plan?</h2>\n<p>Instead of comparing Netflix.shop to Disney or Amazon, investors should look at a Chinese tech company called<b> Bilibili</b> (NASDAQ:BILI) to understand Netflix's angle.</p>\n<p>Bilibili operates a popular streaming-video platform for anime, comics, and gaming (ACG) content in China. It served 223 million monthly active users and 60 million daily active users last quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/44f1ed32c2ba2313bed33d9a885d976b\" tg-width=\"700\" tg-height=\"559\"><span>Image source: Getty Images.</span></p>\n<p>Bilibili also operates an e-commerce site that sells tie-in products for its ACG franchises. The site is integrated with <b>Alibaba</b>'s (NYSE:BABA) Taobao marketplace and accounts for most of Bilibili's \"e-commerce and others\" revenue.</p>\n<p>Bilibili's \"e-commerce and others\" revenue <i>more than doubled </i>last year and accounted for nearly 13% of its top line, which indicates a streaming-video platform that specializes in anime can operate a successful online marketplace for tie-in content.</p>\n<p>That's probably why Netflix repeatedly mentioned \"anime\" in its press release for Netflix.shop.</p>\n<p>Netflix has added a lot of anime and gaming-related content to its streaming library in recent years, including <i>Yasuke</i>, <i>Voltron</i>, <i>Castlevania</i>, <i>The Witcher</i>, and its upcoming<i> Assassin's Creed</i> show. All that niche content could support the expansion of its marketplace for tie-in products, which would possibly lock in more viewers and generate additional revenue.</p>\n<p>Netflix could also offer exclusive discounts for its subscribers, which might convince more of its 208 million subscribers to become regular shoppers. That growth could also convince more companies to license its franchises for third-party products.</p>\n<h2>The bottom line</h2>\n<p>Netflix's retail expansion is surprising but not unprecedented. Instead of comparing Netflix.shop to Disney or Amazon, investors would do well to study Bilibili to gauge Netflix's true growth potential.</p>\n<p>This effort won't move the needle for Netflix anytime soon, but it shows the company is thinking out of the box to promote its franchises and enter new markets. These strategies could help Netflix remain competitive as Disney, Amazon, and other challengers all ramp up their streaming investments.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Do Netflix's Retail Ambitions Make Any Sense?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDo Netflix's Retail Ambitions Make Any Sense?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 22:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/16/do-netflixs-retail-ambitions-make-any-sense/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Netflix (NASDAQ:NFLX) recently launched Netflix.shop, an online store for apparel and lifestyle products, in a surprising leap into the retail sector.\nIts initial products include streetwear and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/16/do-netflixs-retail-ambitions-make-any-sense/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","03086":"华夏纳指","09086":"华夏纳指-U","NFLX":"奈飞"},"source_url":"https://www.fool.com/investing/2021/06/16/do-netflixs-retail-ambitions-make-any-sense/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143792622","content_text":"Netflix (NASDAQ:NFLX) recently launched Netflix.shop, an online store for apparel and lifestyle products, in a surprising leap into the retail sector.\nIts initial products include streetwear and action figures based on the anime series Yasuke and Eden, as well as limited-edition apparel, and products inspired by Lupin and produced in collaboration with the Louvre. It's also selling anime-inspired collectibles from up-and-coming designers like Nathalie Nguyen, Kristopher Kites, and Jordan Bentley.\nNetflix.shop will also eventually sell exclusive tie-in products for popular series like The Witcher and Stranger Things, as well as Netflix-branded apparel from the Japanese fashion house BEAMS. It will initially launch the marketplace in the U.S. before expanding into other countries.\nImage source: Netflix.\nThis doesn't represent Netflix's first attempt at selling tie-in products for its streaming franchises. Target, for example, already carries a wide range of Yasuke products. However, Netflix.shop marks Netflix's first attempt to sell all those tie-in products through its own online marketplace.\nNetflix.shop will spark comparisons to Disney (NYSE:DIS) and Amazon (NASDAQ:AMZN), but is it actually chasing those companies? Or should investors look overseas to understand Netflix's true goals?\nCould Netflix be responding to Disney and Amazon?\nNetflix's online store is much smaller than Disney's (NYSE:DIS) sprawling retail business. At the end of 2020, Disney owned and operated about 200 stores across North America, 60 stores in Europe, 45 stores in Japan, and two stores in China. It also sells its products online and licenses its brands to third-party companies.\nNetflix competes against Disney in the streaming market, but I doubt it will follow Disney's example and open hundreds of brick-and-mortar stores, for three simple reasons.\nFirst, brick-and-mortar stores are more capital-intensive than online stores. It would be absurd for Netflix, which already plans to spend $17 billion on new streaming content this year, to set aside fresh cash for new physical stores instead of expanding its streaming library.\nSecond, physical stores are highly exposed to online competition and the decline of offline shopping. Lastly, Netflix doesn't own as many popular franchises as Disney, which can easily fill its shelves with merchandise from its namesake properties as well as Pixar, Marvel, and Star Wars products.\nNetflix.shop also might seem like an attempt to counter Amazon, which leveraged the strength of its Prime e-commerce ecosystem to tether more viewers to its Prime Video service.\nThat strategy would represent a reversal of Amazon's strategy since Netflix would be leveraging its strength in streaming video to expand into the retail market. But I also doubt Netflix plans to pour billions of dollars into challenging Amazon in the cutthroat e-commerce market.\nSo what's Netflix's game plan?\nInstead of comparing Netflix.shop to Disney or Amazon, investors should look at a Chinese tech company called Bilibili (NASDAQ:BILI) to understand Netflix's angle.\nBilibili operates a popular streaming-video platform for anime, comics, and gaming (ACG) content in China. It served 223 million monthly active users and 60 million daily active users last quarter.\nImage source: Getty Images.\nBilibili also operates an e-commerce site that sells tie-in products for its ACG franchises. The site is integrated with Alibaba's (NYSE:BABA) Taobao marketplace and accounts for most of Bilibili's \"e-commerce and others\" revenue.\nBilibili's \"e-commerce and others\" revenue more than doubled last year and accounted for nearly 13% of its top line, which indicates a streaming-video platform that specializes in anime can operate a successful online marketplace for tie-in content.\nThat's probably why Netflix repeatedly mentioned \"anime\" in its press release for Netflix.shop.\nNetflix has added a lot of anime and gaming-related content to its streaming library in recent years, including Yasuke, Voltron, Castlevania, The Witcher, and its upcoming Assassin's Creed show. All that niche content could support the expansion of its marketplace for tie-in products, which would possibly lock in more viewers and generate additional revenue.\nNetflix could also offer exclusive discounts for its subscribers, which might convince more of its 208 million subscribers to become regular shoppers. That growth could also convince more companies to license its franchises for third-party products.\nThe bottom line\nNetflix's retail expansion is surprising but not unprecedented. Instead of comparing Netflix.shop to Disney or Amazon, investors would do well to study Bilibili to gauge Netflix's true growth potential.\nThis effort won't move the needle for Netflix anytime soon, but it shows the company is thinking out of the box to promote its franchises and enter new markets. These strategies could help Netflix remain competitive as Disney, Amazon, and other challengers all ramp up their streaming investments.","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":818440623,"gmtCreate":1630435284462,"gmtModify":1633678109093,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/818440623","repostId":"1173998132","repostType":4,"isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834706889,"gmtCreate":1629826611441,"gmtModify":1633682165778,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/834706889","repostId":"1118949007","repostType":4,"repost":{"id":"1118949007","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629815206,"share":"https://www.laohu8.com/m/news/1118949007?lang=&edition=full","pubTime":"2021-08-24 22:26","market":"us","language":"en","title":"Alphabet shares rose 1.3% to a new high","url":"https://stock-news.laohu8.com/highlight/detail?id=1118949007","media":"Tiger Newspress","summary":"Alphabet shares rose 1.3% to a new high.\n\nBy and large, investors know Alphabet Inc. (GOOGL) as the ","content":"<p>Alphabet shares rose 1.3% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/ab79065de74f4b0228bb6a8dd5a1ec02\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>By and large, investors know Alphabet Inc. (<b>GOOGL</b>) as the parent company of the search engine that everybody and their uncle uses: Google. I am definitely bullish on GOOGL stock.</p>\n<p>Amazingly, the Google search portal is so famous that in the popular lexicon, “Google” is both a noun and a verb.</p>\n<p>It’s perfectly fine to invest in GOOGL stock because so many people use the company’s search engine. However, stock traders might also choose to look at other angles when considering an investment.</p>\n<p>As we’ll see, the stock could actually be considered a bargain. Moreover, Google’s products give customers what they want: the latest in cutting-edge communications technology.</p>\n<p><b>A Quick Look at GOOGL Stock</b></p>\n<p>At first glance, it might seem ridiculous to say that GOOGL stock is cheap. After all, this is a stock that costs nearly $3,000 per share.</p>\n<p>Moreover, GOOGL stock reached a new 52-week high of $2,817.49 on Monday. It has steadily gone up over the past year, with hardly any breaks or corrections.</p>\n<p>That should be fine for momentum-focused traders, but value-oriented investors might think that GOOGL stock is too expensive to buy now.</p>\n<p>Yet, let’s consider a different angle. If the company’s earnings are robust, then the high price tag of the stock might be fully justified.</p>\n<p>As it turns out, Alphabet’s trailing 12-month price-to-earnings ratio is 30.5. That’s not too bad, especially for a technology stock in 2021.</p>\n<p>So, just maybe, GOOGL stock is still a bargain after all.</p>\n<p><b>Meet the New Google Meet</b></p>\n<p>If you’re going to take away anything from this, it should be that there’s more to Google than its search engine.</p>\n<p>One example would be Google Meet, the company’s video-conferencing software.</p>\n<p>Without a doubt, Google would like to capture a bigger share of the visual-communication software market.<i>Fortune Business Insights</i>reported that this market was worth $5.77 billion in 2020.</p>\n<p>Furthermore, this market is projected to reach $6.28 billion in 2021, and $12.99 billion in 2028, thereby exhibiting a CAGR of 10.9% from 2021 to 2028.</p>\n<p>Google Meet’s new features should help the company take a bigger slice of this rich pie.</p>\n<p>The new features include the ability to add up to 25 co-hosts for meetings. Furthermore, hosts and co-hosts will be able to limit the number of users who can share screens, send messages, and mute others.</p>\n<p><b>An Affordable Smartphone</b></p>\n<p>Let’s face it: not everyone is ready to buy a $1,200 smartphone.</p>\n<p>At the same time, people want high quality. Now, with the launch of the Google Pixel 5a, shoppers don’t have to compromise quality or affordability.</p>\n<p>Granted, Google already unveiled its Pixel 6 and Pixel Pro smartphones, but those are high-end and pricier. There’s a market for lower-priced smartphones, and Google is aggressively pursuing this market with the Pixel 5a.</p>\n<p>We’re talking about a $449 price tag, which is less than half the price of the most expensive smartphones on the market today.</p>\n<p>Some of the phone’s features include 5G functionality, a dual-camera system, and IP67 water and dust resistance.</p>\n<p><b>Wall Street Weighs In</b></p>\n<p>According to TipRanks’ analyst rating consensus, GOOGL is a Strong Buy, based on 29 unanimous Buy ratings. The&nbsp;average Alphabet price target&nbsp;is $3,176.18, implying 13.4% upside potential.</p>\n<p><img src=\"https://static.tigerbbs.com/28be6712f40ae45fa1c1ca53a6200ce0\" tg-width=\"1536\" tg-height=\"580\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n<p></p>\n<p><b>Takeaways</b></p>\n<p>While GOOGL stock might seem expensive — and there’s no denying that it’s pricey — a valuation analysis reveals that it’s also a pretty good bargain.</p>\n<p>Just as importantly, Alphabet shouldn’t be pigeonholed as just a search-engine provider.</p>\n<p>The company is expanding quickly into other value-added markets with intriguing products and services, which prospective investors should take into consideration.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alphabet shares rose 1.3% to a new high</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlphabet shares rose 1.3% to a new high\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-24 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alphabet shares rose 1.3% to a new high.</p>\n<p><img src=\"https://static.tigerbbs.com/ab79065de74f4b0228bb6a8dd5a1ec02\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>By and large, investors know Alphabet Inc. (<b>GOOGL</b>) as the parent company of the search engine that everybody and their uncle uses: Google. I am definitely bullish on GOOGL stock.</p>\n<p>Amazingly, the Google search portal is so famous that in the popular lexicon, “Google” is both a noun and a verb.</p>\n<p>It’s perfectly fine to invest in GOOGL stock because so many people use the company’s search engine. However, stock traders might also choose to look at other angles when considering an investment.</p>\n<p>As we’ll see, the stock could actually be considered a bargain. Moreover, Google’s products give customers what they want: the latest in cutting-edge communications technology.</p>\n<p><b>A Quick Look at GOOGL Stock</b></p>\n<p>At first glance, it might seem ridiculous to say that GOOGL stock is cheap. After all, this is a stock that costs nearly $3,000 per share.</p>\n<p>Moreover, GOOGL stock reached a new 52-week high of $2,817.49 on Monday. It has steadily gone up over the past year, with hardly any breaks or corrections.</p>\n<p>That should be fine for momentum-focused traders, but value-oriented investors might think that GOOGL stock is too expensive to buy now.</p>\n<p>Yet, let’s consider a different angle. If the company’s earnings are robust, then the high price tag of the stock might be fully justified.</p>\n<p>As it turns out, Alphabet’s trailing 12-month price-to-earnings ratio is 30.5. That’s not too bad, especially for a technology stock in 2021.</p>\n<p>So, just maybe, GOOGL stock is still a bargain after all.</p>\n<p><b>Meet the New Google Meet</b></p>\n<p>If you’re going to take away anything from this, it should be that there’s more to Google than its search engine.</p>\n<p>One example would be Google Meet, the company’s video-conferencing software.</p>\n<p>Without a doubt, Google would like to capture a bigger share of the visual-communication software market.<i>Fortune Business Insights</i>reported that this market was worth $5.77 billion in 2020.</p>\n<p>Furthermore, this market is projected to reach $6.28 billion in 2021, and $12.99 billion in 2028, thereby exhibiting a CAGR of 10.9% from 2021 to 2028.</p>\n<p>Google Meet’s new features should help the company take a bigger slice of this rich pie.</p>\n<p>The new features include the ability to add up to 25 co-hosts for meetings. Furthermore, hosts and co-hosts will be able to limit the number of users who can share screens, send messages, and mute others.</p>\n<p><b>An Affordable Smartphone</b></p>\n<p>Let’s face it: not everyone is ready to buy a $1,200 smartphone.</p>\n<p>At the same time, people want high quality. Now, with the launch of the Google Pixel 5a, shoppers don’t have to compromise quality or affordability.</p>\n<p>Granted, Google already unveiled its Pixel 6 and Pixel Pro smartphones, but those are high-end and pricier. There’s a market for lower-priced smartphones, and Google is aggressively pursuing this market with the Pixel 5a.</p>\n<p>We’re talking about a $449 price tag, which is less than half the price of the most expensive smartphones on the market today.</p>\n<p>Some of the phone’s features include 5G functionality, a dual-camera system, and IP67 water and dust resistance.</p>\n<p><b>Wall Street Weighs In</b></p>\n<p>According to TipRanks’ analyst rating consensus, GOOGL is a Strong Buy, based on 29 unanimous Buy ratings. The&nbsp;average Alphabet price target&nbsp;is $3,176.18, implying 13.4% upside potential.</p>\n<p><img src=\"https://static.tigerbbs.com/28be6712f40ae45fa1c1ca53a6200ce0\" tg-width=\"1536\" tg-height=\"580\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n<p></p>\n<p><b>Takeaways</b></p>\n<p>While GOOGL stock might seem expensive — and there’s no denying that it’s pricey — a valuation analysis reveals that it’s also a pretty good bargain.</p>\n<p>Just as importantly, Alphabet shouldn’t be pigeonholed as just a search-engine provider.</p>\n<p>The company is expanding quickly into other value-added markets with intriguing products and services, which prospective investors should take into consideration.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","GOOGL":"谷歌A"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118949007","content_text":"Alphabet shares rose 1.3% to a new high.\n\nBy and large, investors know Alphabet Inc. (GOOGL) as the parent company of the search engine that everybody and their uncle uses: Google. I am definitely bullish on GOOGL stock.\nAmazingly, the Google search portal is so famous that in the popular lexicon, “Google” is both a noun and a verb.\nIt’s perfectly fine to invest in GOOGL stock because so many people use the company’s search engine. However, stock traders might also choose to look at other angles when considering an investment.\nAs we’ll see, the stock could actually be considered a bargain. Moreover, Google’s products give customers what they want: the latest in cutting-edge communications technology.\nA Quick Look at GOOGL Stock\nAt first glance, it might seem ridiculous to say that GOOGL stock is cheap. After all, this is a stock that costs nearly $3,000 per share.\nMoreover, GOOGL stock reached a new 52-week high of $2,817.49 on Monday. It has steadily gone up over the past year, with hardly any breaks or corrections.\nThat should be fine for momentum-focused traders, but value-oriented investors might think that GOOGL stock is too expensive to buy now.\nYet, let’s consider a different angle. If the company’s earnings are robust, then the high price tag of the stock might be fully justified.\nAs it turns out, Alphabet’s trailing 12-month price-to-earnings ratio is 30.5. That’s not too bad, especially for a technology stock in 2021.\nSo, just maybe, GOOGL stock is still a bargain after all.\nMeet the New Google Meet\nIf you’re going to take away anything from this, it should be that there’s more to Google than its search engine.\nOne example would be Google Meet, the company’s video-conferencing software.\nWithout a doubt, Google would like to capture a bigger share of the visual-communication software market.Fortune Business Insightsreported that this market was worth $5.77 billion in 2020.\nFurthermore, this market is projected to reach $6.28 billion in 2021, and $12.99 billion in 2028, thereby exhibiting a CAGR of 10.9% from 2021 to 2028.\nGoogle Meet’s new features should help the company take a bigger slice of this rich pie.\nThe new features include the ability to add up to 25 co-hosts for meetings. Furthermore, hosts and co-hosts will be able to limit the number of users who can share screens, send messages, and mute others.\nAn Affordable Smartphone\nLet’s face it: not everyone is ready to buy a $1,200 smartphone.\nAt the same time, people want high quality. Now, with the launch of the Google Pixel 5a, shoppers don’t have to compromise quality or affordability.\nGranted, Google already unveiled its Pixel 6 and Pixel Pro smartphones, but those are high-end and pricier. There’s a market for lower-priced smartphones, and Google is aggressively pursuing this market with the Pixel 5a.\nWe’re talking about a $449 price tag, which is less than half the price of the most expensive smartphones on the market today.\nSome of the phone’s features include 5G functionality, a dual-camera system, and IP67 water and dust resistance.\nWall Street Weighs In\nAccording to TipRanks’ analyst rating consensus, GOOGL is a Strong Buy, based on 29 unanimous Buy ratings. The average Alphabet price target is $3,176.18, implying 13.4% upside potential.\n\n\n\nTakeaways\nWhile GOOGL stock might seem expensive — and there’s no denying that it’s pricey — a valuation analysis reveals that it’s also a pretty good bargain.\nJust as importantly, Alphabet shouldn’t be pigeonholed as just a search-engine provider.\nThe company is expanding quickly into other value-added markets with intriguing products and services, which prospective investors should take into consideration.","news_type":1},"isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834701017,"gmtCreate":1629826015139,"gmtModify":1633682167032,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/834701017","repostId":"2161818081","repostType":4,"repost":{"id":"2161818081","kind":"highlight","pubTimestamp":1629819036,"share":"https://www.laohu8.com/m/news/2161818081?lang=&edition=full","pubTime":"2021-08-24 23:30","market":"us","language":"en","title":"Here's Why Visa Is One of the Best Long-Term Stocks to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2161818081","media":"Motley Fool","summary":"The largest payments network is still growing.","content":"<p>If you're like millions of people, you've already used your <b><a href=\"https://laohu8.com/S/V\">Visa</a></b>&nbsp;(NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.</p>\n<p>The payment network took a big hit during the early stages of the pandemic, when consumer spending plunged. But it's rebounding along with the economy, and that's where its strength lies. As the largest credit card network in the world, it makes money whenever you swipe your card, making this blue-chip company a surefire bet for long-term growth.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F636551%2Fgettyimages-1331306883.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Powering payments</h2>\n<p>Visa's network facilitates payments from consumers to merchants and takes a small fee from each transaction. The sheer number of people who use Visa credit cards demonstrates the company's dominance in the market -- there are currently 3.6 billion Visa cards in use, which translates into almost half the world's population. In 2019, Visa processed more than 200 billion transactions, or more than $11 trillion in volume.</p>\n<p>Because Visa's model is a platform, it's a high-margin business that easily turns sales into profits. Operating margin was over 66% in Q3, and Visa turned $6.1 billion in revenue into $2.6 billion in net income. It also produced more than $4 billion in free cash flow, which it uses to grow its business as well as pay dividends and repurchase stock.</p>\n<p>Business plummeted during the height of pandemic restrictions, but the recovery is moving along. Revenue for the company's fiscal third quarter, covering the period ended June 30, increased 27% from the same period in 2020, but&nbsp; 10% over pre-pandemic 2019 levels.</p>\n<p>Because the pandemic was such an outlier, we can see Visa's strength more clearly in its long-term growth. As of the latest quarter, Visa has grown revenue by a 9.5%&nbsp;compound annual growth rate (CAGR) over the past five years, and net income by an even better rate of 14.3%.</p>\n<h2>Fintech revolution</h2>\n<p>One of the ways Visa is protecting its top spot in credit card processing is acquiring and making deals with fintech partners. Its proposed acquisition of Plaid, a private company that connects financial apps with institutions, was scrapped after it was given a no-go by regulators. But it's made many smaller acquisitions to grow its business and especially to stay relevant as digital payments become more important. Most recently, it acquired Currencycloud, an app that simplifies foreign exchange to make cross-border payments easier. In Q3, it also announced that it would acquire Tink, a Swedish-based open banking platform.</p>\n<p>Visa needs to upgrade its systems as companies like <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings</b>&nbsp;make it easier to send and spend money digitally. Contactless payments are increasing in popularity, and in the U.S. alone Visa customers have more than 370 million tap-to-pay cards. Installment plans have also taken off, with companies such as <b>Afterpay</b>&nbsp;(recently acquired by <b>Square</b>) and <b>Affirm Holdings</b>&nbsp;demonstrating strong growth, and Visa has launched its own version as well.</p>\n<h2>Rewarding investors</h2>\n<p>At Monday's prices, Visa's stock has gained roughly 190% over the past five years, almost double the <b>S&amp;P 500</b> index. While it's trailing the broader market over the past year, it's still up nearly 15% as it's dealt with the weight of the pandemic. Its dividend yields 0.55% at the current price, well below the S&amp;P 500 average, but the company has raised its payout annually since 2008.</p>\n<p>Since it generally mirrors the state of the economy, which an overwhelming amount of the time expands rather than contracts, Visa is great long-term stock to own. Its top position makes it hard to compete with, and it can provide security and stability to a balanced portfolio.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Visa Is One of the Best Long-Term Stocks to Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Visa Is One of the Best Long-Term Stocks to Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If you're like millions of people, you've already used your Visa (NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.\nThe payment network took...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa"},"source_url":"https://www.fool.com/investing/2021/08/24/heres-why-visa-is-one-of-the-best-long-term-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2161818081","content_text":"If you're like millions of people, you've already used your Visa (NYSE:V) card today. And that reach is what makes Visa stand out as a business investors want to be a part of.\nThe payment network took a big hit during the early stages of the pandemic, when consumer spending plunged. But it's rebounding along with the economy, and that's where its strength lies. As the largest credit card network in the world, it makes money whenever you swipe your card, making this blue-chip company a surefire bet for long-term growth.\nImage source: Getty Images.\nPowering payments\nVisa's network facilitates payments from consumers to merchants and takes a small fee from each transaction. The sheer number of people who use Visa credit cards demonstrates the company's dominance in the market -- there are currently 3.6 billion Visa cards in use, which translates into almost half the world's population. In 2019, Visa processed more than 200 billion transactions, or more than $11 trillion in volume.\nBecause Visa's model is a platform, it's a high-margin business that easily turns sales into profits. Operating margin was over 66% in Q3, and Visa turned $6.1 billion in revenue into $2.6 billion in net income. It also produced more than $4 billion in free cash flow, which it uses to grow its business as well as pay dividends and repurchase stock.\nBusiness plummeted during the height of pandemic restrictions, but the recovery is moving along. Revenue for the company's fiscal third quarter, covering the period ended June 30, increased 27% from the same period in 2020, but  10% over pre-pandemic 2019 levels.\nBecause the pandemic was such an outlier, we can see Visa's strength more clearly in its long-term growth. As of the latest quarter, Visa has grown revenue by a 9.5% compound annual growth rate (CAGR) over the past five years, and net income by an even better rate of 14.3%.\nFintech revolution\nOne of the ways Visa is protecting its top spot in credit card processing is acquiring and making deals with fintech partners. Its proposed acquisition of Plaid, a private company that connects financial apps with institutions, was scrapped after it was given a no-go by regulators. But it's made many smaller acquisitions to grow its business and especially to stay relevant as digital payments become more important. Most recently, it acquired Currencycloud, an app that simplifies foreign exchange to make cross-border payments easier. In Q3, it also announced that it would acquire Tink, a Swedish-based open banking platform.\nVisa needs to upgrade its systems as companies like PayPal Holdings make it easier to send and spend money digitally. Contactless payments are increasing in popularity, and in the U.S. alone Visa customers have more than 370 million tap-to-pay cards. Installment plans have also taken off, with companies such as Afterpay (recently acquired by Square) and Affirm Holdings demonstrating strong growth, and Visa has launched its own version as well.\nRewarding investors\nAt Monday's prices, Visa's stock has gained roughly 190% over the past five years, almost double the S&P 500 index. While it's trailing the broader market over the past year, it's still up nearly 15% as it's dealt with the weight of the pandemic. Its dividend yields 0.55% at the current price, well below the S&P 500 average, but the company has raised its payout annually since 2008.\nSince it generally mirrors the state of the economy, which an overwhelming amount of the time expands rather than contracts, Visa is great long-term stock to own. Its top position makes it hard to compete with, and it can provide security and stability to a balanced portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":215,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818440405,"gmtCreate":1630435416807,"gmtModify":1633678108868,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Will more companies continue to hold virtual meeting?","listText":"Will more companies continue to hold virtual meeting?","text":"Will more companies continue to hold virtual meeting?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/818440405","repostId":"1155259610","repostType":4,"repost":{"id":"1155259610","kind":"news","pubTimestamp":1630421174,"share":"https://www.laohu8.com/m/news/1155259610?lang=&edition=full","pubTime":"2021-08-31 22:46","market":"us","language":"en","title":"ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1155259610","media":"investorplace","summary":"Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of t","content":"<p><b>Zoom Video Communications</b>(NASDAQ:<b><u>ZM</u></b>) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.</p>\n<p>Let’s dive into that earnings report below to see what has ZM stock falling today.</p>\n<ul>\n <li>The biggest problem facing Zoom Video this morning is its guidance for the upcoming quarter.</li>\n <li>That begins with an outlook for Q3 that includes&nbsp;adjusted earnings per share of $1.07 to $1.08.</li>\n <li>This would have it missing Wall Street’s estimate of $1.09 for the quarter.</li>\n <li>There’s also the fact that Zoom Video is seeing slower growth now that lockdowns are coming to an end.</li>\n <li>That’s a result of schools and businesses using the company’s services less and less to hold virtual meetings.</li>\n <li>These are pulling down an otherwise solid earnings report for the company.</li>\n <li>Its adjusted earnings per share for the current quarter was $1.36, which beat out Wall Street’s estimate of $1.16.</li>\n <li>Revenue of $1.02 billion was also better than the $990.96 million that analysts were expecting.</li>\n</ul>\n<p>Eric Yuan, founder and CEO of Zoom Video, said the following in the earnings report affecting ZM stock today.</p>\n<blockquote>\n “In Q2, we achieved our first billion dollar revenue quarter while delivering strong profitability and cash flow. Q2 also marked several milestones on our expansion beyond the UC platform. We launched Zoom Apps, bringing over 50 apps directly into the Zoom experience, and Zoom Events, an all-in-one digital events service.”\n</blockquote>\n<p>It’s also worth pointing out that ZM stock is seeing heavy trading alongside this news. As of this writing, more than 15 million shares of the stock have changed hands. That’s a significant increase over its daily average trading volume of about 3.2 million shares.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZM Stock Alert: 8 Reasons Why Zoom Video Is Tumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-31 22:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.\nLet’s dive into that earnings ...</p>\n\n<a href=\"https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"source_url":"https://investorplace.com/2021/08/zm-stock-alert-8-reasons-why-zoom-video-is-tumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155259610","content_text":"Zoom Video Communications(NASDAQ:ZM) stock is taking a beating on Tuesday following the release of the company’s earnings report for the second quarter of fiscal 2022.\nLet’s dive into that earnings report below to see what has ZM stock falling today.\n\nThe biggest problem facing Zoom Video this morning is its guidance for the upcoming quarter.\nThat begins with an outlook for Q3 that includes adjusted earnings per share of $1.07 to $1.08.\nThis would have it missing Wall Street’s estimate of $1.09 for the quarter.\nThere’s also the fact that Zoom Video is seeing slower growth now that lockdowns are coming to an end.\nThat’s a result of schools and businesses using the company’s services less and less to hold virtual meetings.\nThese are pulling down an otherwise solid earnings report for the company.\nIts adjusted earnings per share for the current quarter was $1.36, which beat out Wall Street’s estimate of $1.16.\nRevenue of $1.02 billion was also better than the $990.96 million that analysts were expecting.\n\nEric Yuan, founder and CEO of Zoom Video, said the following in the earnings report affecting ZM stock today.\n\n “In Q2, we achieved our first billion dollar revenue quarter while delivering strong profitability and cash flow. Q2 also marked several milestones on our expansion beyond the UC platform. We launched Zoom Apps, bringing over 50 apps directly into the Zoom experience, and Zoom Events, an all-in-one digital events service.”\n\nIt’s also worth pointing out that ZM stock is seeing heavy trading alongside this news. As of this writing, more than 15 million shares of the stock have changed hands. That’s a significant increase over its daily average trading volume of about 3.2 million shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832955495,"gmtCreate":1629567875117,"gmtModify":1633684015904,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Great news. Please help to like","listText":"Great news. Please help to like","text":"Great news. Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/832955495","repostId":"2161745179","repostType":4,"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810476834,"gmtCreate":1629999498828,"gmtModify":1704954431941,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Interesting. Please help to like too","listText":"Interesting. Please help to like too","text":"Interesting. Please help to like too","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810476834","repostId":"2162018921","repostType":4,"repost":{"id":"2162018921","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1629993272,"share":"https://www.laohu8.com/m/news/2162018921?lang=&edition=full","pubTime":"2021-08-26 23:54","market":"hk","language":"en","title":"These 20 'left behind' stocks among the S&P 500 are expected to rise up to 59% over 12 months","url":"https://stock-news.laohu8.com/highlight/detail?id=2162018921","media":"Dow Jones","summary":"Some surprises among the small number of stocks that are down for 2021\nThe S&P 500 index closed at a","content":"<p>Some surprises among the small number of stocks that are down for 2021</p>\n<p>The S&amp;P 500 index closed at another all-time high on Wednesday, its 51st record this year. Success has been widespread, with 250 of the S&amp;P 500 outperforming the index as a whole. But there are always some stocks left behind, including the list of highly regarded names below.</p>\n<p><a href=\"https://laohu8.com/S/FBNC\">First</a>, consider how well the S&amp;P 500 has been performing. It was up 20.8% for 2021 through Aug. 25, with dividends reinvested. That follows returns of 32.5% in 2020 and 31.5% in 2019. The index has returned 88.1% since the end of 2018. All performance figures in this article include reinvested dividends.</p>\n<p>If we even out the numbers, the S&amp;P 500 has returned 65% for three years, 128% for five years and 375% for 10 years, underlining the case for stocks as the ideal asset class for most long-term investors. Performance slips if we go out 15 years to cover the 2008 financial crisis, with a return of 367%.</p>\n<p>Stocks left behind in 2021 that may have great potential for investors</p>\n<p>Through Aug. 25, 58 of the S&amp;P 500 components were down for 2021. Among those stocks, 33 have majority \"buy\" ratings among analysts polled by FactSet. Here are the 20 that the analysts expect to perform the best over the next 12 months, along with their forward price-to-earnings ratios:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td><a href=\"https://laohu8.com/S/TSS\">Total</a> return -- 2021</td>\n   <td>Share \"buy\" ratings</td>\n   <td>Closing price -- Aug. 25</td>\n   <td>Consensus price target</td>\n   <td>Implied 12-month upside potential</td>\n   <td><a href=\"https://laohu8.com/S/FORD\">Forward</a> P/E</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MU\">Micron Technology</a> Inc. MU</td>\n   <td>-2%</td>\n   <td>85%</td>\n   <td>$74.04</td>\n   <td>$117.79</td>\n   <td>59%</td>\n   <td>7.0</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/LVS\">Las Vegas Sands</a> Corp. LVS</td>\n   <td>-27%</td>\n   <td>63%</td>\n   <td>$43.24</td>\n   <td>$64.38</td>\n   <td>49%</td>\n   <td>44.7</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ATVI\">Activision Blizzard</a> Inc. ATVI</td>\n   <td>-13%</td>\n   <td>91%</td>\n   <td>$80.81</td>\n   <td>$116.04</td>\n   <td>44%</td>\n   <td>21.1</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GPN\">Global Payments</a> Inc. GPN</td>\n   <td>-23%</td>\n   <td>81%</td>\n   <td>$165.25</td>\n   <td>$228.69</td>\n   <td>38%</td>\n   <td>18.6</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/INCY\">Incyte</a> Corp. INCY</td>\n   <td>-13%</td>\n   <td>60%</td>\n   <td>$75.76</td>\n   <td>$102.47</td>\n   <td>35%</td>\n   <td>32.2</td>\n  </tr>\n  <tr>\n   <td>NOV Inc. NOV</td>\n   <td>-3%</td>\n   <td>59%</td>\n   <td>$13.26</td>\n   <td>$17.58</td>\n   <td>33%</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>$Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> Interactive Software(TTWO)$ Inc. TTWO</td>\n   <td>-23%</td>\n   <td>70%</td>\n   <td>$160.66</td>\n   <td>$212.87</td>\n   <td>32%</td>\n   <td>34.2</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FMC\">FMC Corp.</a> FMC</td>\n   <td>-18%</td>\n   <td>75%</td>\n   <td>$92.90</td>\n   <td>$122.89</td>\n   <td>32%</td>\n   <td>12.8</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/VRTX\">Vertex Pharmaceuticals</a> Inc. VRTX</td>\n   <td>-15%</td>\n   <td>78%</td>\n   <td>$201.33</td>\n   <td>$262.14</td>\n   <td>30%</td>\n   <td>16.2</td>\n  </tr>\n  <tr>\n   <td>Newmont Corp. NEM</td>\n   <td>-3%</td>\n   <td>71%</td>\n   <td>$56.91</td>\n   <td>$73.57</td>\n   <td>29%</td>\n   <td>16.3</td>\n  </tr>\n  <tr>\n   <td>Lamb Weston Holdings Inc. LW</td>\n   <td>-15%</td>\n   <td>78%</td>\n   <td>$66.09</td>\n   <td>$85.43</td>\n   <td>29%</td>\n   <td>26.5</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a> Inc. QCOM</td>\n   <td>-5%</td>\n   <td>64%</td>\n   <td>$143.87</td>\n   <td>$184.15</td>\n   <td>28%</td>\n   <td>15.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FIS\">Fidelity National Information</a> Services Inc. FIS</td>\n   <td>-8%</td>\n   <td>69%</td>\n   <td>$130.01</td>\n   <td>$165.93</td>\n   <td>28%</td>\n   <td>18.3</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PENN\">Penn National Gaming</a> Inc. PENN</td>\n   <td>-7%</td>\n   <td>67%</td>\n   <td>$79.92</td>\n   <td>$101.50</td>\n   <td>27%</td>\n   <td>26.3</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/BAX\">Baxter</a> International Inc. BAX</td>\n   <td>-7%</td>\n   <td>53%</td>\n   <td>$73.80</td>\n   <td>$92.56</td>\n   <td>25%</td>\n   <td>19.5</td>\n  </tr>\n  <tr>\n   <td>V.F. Corp. VFC</td>\n   <td>-9%</td>\n   <td>68%</td>\n   <td>$77.06</td>\n   <td>$96.59</td>\n   <td>25%</td>\n   <td>23.1</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ZBH\">Zimmer Biomet Holdings Inc</a>. ZBH</td>\n   <td>-2%</td>\n   <td>79%</td>\n   <td>$150.39</td>\n   <td>$187.58</td>\n   <td>25%</td>\n   <td>18.1</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/STZ\">Constellation Brands Inc</a>. Class A STZ</td>\n   <td>-1%</td>\n   <td>71%</td>\n   <td>$214.98</td>\n   <td>$265.86</td>\n   <td>24%</td>\n   <td>20.6</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WYNN\">Wynn</a> Resorts Ltd. WYNN</td>\n   <td>-11%</td>\n   <td>54%</td>\n   <td>$100.84</td>\n   <td>$123.45</td>\n   <td>22%</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/EA\">Electronic Arts</a> Inc. EA</td>\n   <td>-1%</td>\n   <td>72%</td>\n   <td>$141.86</td>\n   <td>$172.75</td>\n   <td>22%</td>\n   <td>20.4</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>You can click on the tickers for more about each company.</p>\n<p>The list is meant to provide information -- it is not investment advice. Here's some advice: If you see any stock of interest here, do your own research to form your own opinion about the company's strategy and its long-term prospects.</p>\n<p>Market-cap weighting is less important this year</p>\n<p>The S&amp;P 500 is weighted by market capitalization, which means its performance can be dominated by the largest stocks in the index.</p>\n<p>The SPDR S&amp;P 500 ETF <a href=\"https://laohu8.com/S/SPY.AU\">$(SPY.AU)$</a> tracks the benchmark index by holding shares of all 500 companies and charging nominal annual fees totaling 0.09% of assets. Its five largest holdings (including two common-share classes for <a href=\"https://laohu8.com/S/GOOG\">Alphabet</a> Inc. <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL)) make up 22.6% of the portfolio. Here's how they have performed:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Total return -- 2021</td>\n   <td>Total return -- 2020</td>\n   <td>Total return -- 2019</td>\n   <td>Total return -- 3 Years</td>\n   <td>Total return -- 5 Years</td>\n   <td>% of SPY portfolio</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc. AAPL</td>\n   <td>12.3%</td>\n   <td>82%</td>\n   <td>89%</td>\n   <td>183.4%</td>\n   <td>488.3%</td>\n   <td>6.2%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> Corp MSFT.</td>\n   <td>36.7%</td>\n   <td>43%</td>\n   <td>58%</td>\n   <td>188.9%</td>\n   <td>461.1%</td>\n   <td>6.0%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc. AMZN</td>\n   <td>1.3%</td>\n   <td>76%</td>\n   <td>23%</td>\n   <td>73.1%</td>\n   <td>334.5%</td>\n   <td>3.7%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc. Class A</td>\n   <td>34.9%</td>\n   <td>33%</td>\n   <td>57%</td>\n   <td>110.9%</td>\n   <td>197.4%</td>\n   <td>2.3%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GOOGL\">Alphabet</a> Inc. Class A GOOGL</td>\n   <td>62.1%</td>\n   <td>31%</td>\n   <td>28%</td>\n   <td>129.8%</td>\n   <td>259.1%</td>\n   <td>2.2%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C GOOG</td>\n   <td>63.2%</td>\n   <td>31%</td>\n   <td>29%</td>\n   <td>134.2%</td>\n   <td>271.6%</td>\n   <td>2.1%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>A very good 2021 so far, but you can see that Apple Inc. <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> and especially Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> have underperformed the index this year.</p>\n<p>This brings up another fascinating development related to cap-weighting that underscores how widespread good stock performance has been during 2021. This year, the <a href=\"https://laohu8.com/S/IVZ\">Invesco</a> S&amp;P 500 Equal Weight ETF <a href=\"https://laohu8.com/S/RSP\">$(RSP)$</a> has outperformed SPY and the S&amp;P 500:</p>\n<p>The weighted forward P/E ratio for the S&amp;P 500 is 21.1, according to FactSet. For comparison, the Invesco S&amp;P 500 Equal Weight ETF (RSP) has a forward P/E is 18.4.</p>\n<p>The equal-weighted approach is, arguably, less risky than the cap-weighted approach, because an investor avoids such a large concentration in a handful of stocks. But during the S&amp;P 500's strong run in recent years, the equal-weighted portfolio has underperformed the index. Here are average annual returns for various periods:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Fund or index</td>\n   <td>Average return -- 3 years</td>\n   <td>Average return -- 5 years</td>\n   <td>Average return -- 10 years</td>\n   <td>Average return -- 15 years</td>\n   <td>Average return -- 17 years</td>\n  </tr>\n  <tr>\n   <td>Invesco S&amp;P 500 Equal Weight ETF RSP</td>\n   <td>15.7%</td>\n   <td>15.2%</td>\n   <td>15.7%</td>\n   <td>10.8%</td>\n   <td>11.0%</td>\n  </tr>\n  <tr>\n   <td>SPDR S&amp;P 500 ETF Trust SPY</td>\n   <td>18.1%</td>\n   <td>17.8%</td>\n   <td>16.7%</td>\n   <td>10.8%</td>\n   <td>10.7%</td>\n  </tr>\n  <tr>\n   <td>S&amp;P 500 SPX</td>\n   <td>18.2%</td>\n   <td>17.9%</td>\n   <td>16.9%</td>\n   <td>10.9%</td>\n   <td>10.8%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>RSP was established in August 2003, so the longest period for the average returns shown above is 17 years. For that period, the equal-weighed has approach performed best, while it has underperformed the cap-weighted index in all the more recent periods. Click here for Mark Hulbert's analysis of the weighted vs. unweighted approaches going back to 1970.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 20 'left behind' stocks among the S&P 500 are expected to rise up to 59% over 12 months</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 20 'left behind' stocks among the S&P 500 are expected to rise up to 59% over 12 months\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-26 23:54</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some surprises among the small number of stocks that are down for 2021</p>\n<p>The S&amp;P 500 index closed at another all-time high on Wednesday, its 51st record this year. Success has been widespread, with 250 of the S&amp;P 500 outperforming the index as a whole. But there are always some stocks left behind, including the list of highly regarded names below.</p>\n<p><a href=\"https://laohu8.com/S/FBNC\">First</a>, consider how well the S&amp;P 500 has been performing. It was up 20.8% for 2021 through Aug. 25, with dividends reinvested. That follows returns of 32.5% in 2020 and 31.5% in 2019. The index has returned 88.1% since the end of 2018. All performance figures in this article include reinvested dividends.</p>\n<p>If we even out the numbers, the S&amp;P 500 has returned 65% for three years, 128% for five years and 375% for 10 years, underlining the case for stocks as the ideal asset class for most long-term investors. Performance slips if we go out 15 years to cover the 2008 financial crisis, with a return of 367%.</p>\n<p>Stocks left behind in 2021 that may have great potential for investors</p>\n<p>Through Aug. 25, 58 of the S&amp;P 500 components were down for 2021. Among those stocks, 33 have majority \"buy\" ratings among analysts polled by FactSet. Here are the 20 that the analysts expect to perform the best over the next 12 months, along with their forward price-to-earnings ratios:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td><a href=\"https://laohu8.com/S/TSS\">Total</a> return -- 2021</td>\n   <td>Share \"buy\" ratings</td>\n   <td>Closing price -- Aug. 25</td>\n   <td>Consensus price target</td>\n   <td>Implied 12-month upside potential</td>\n   <td><a href=\"https://laohu8.com/S/FORD\">Forward</a> P/E</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MU\">Micron Technology</a> Inc. MU</td>\n   <td>-2%</td>\n   <td>85%</td>\n   <td>$74.04</td>\n   <td>$117.79</td>\n   <td>59%</td>\n   <td>7.0</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/LVS\">Las Vegas Sands</a> Corp. LVS</td>\n   <td>-27%</td>\n   <td>63%</td>\n   <td>$43.24</td>\n   <td>$64.38</td>\n   <td>49%</td>\n   <td>44.7</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ATVI\">Activision Blizzard</a> Inc. ATVI</td>\n   <td>-13%</td>\n   <td>91%</td>\n   <td>$80.81</td>\n   <td>$116.04</td>\n   <td>44%</td>\n   <td>21.1</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GPN\">Global Payments</a> Inc. GPN</td>\n   <td>-23%</td>\n   <td>81%</td>\n   <td>$165.25</td>\n   <td>$228.69</td>\n   <td>38%</td>\n   <td>18.6</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/INCY\">Incyte</a> Corp. INCY</td>\n   <td>-13%</td>\n   <td>60%</td>\n   <td>$75.76</td>\n   <td>$102.47</td>\n   <td>35%</td>\n   <td>32.2</td>\n  </tr>\n  <tr>\n   <td>NOV Inc. NOV</td>\n   <td>-3%</td>\n   <td>59%</td>\n   <td>$13.26</td>\n   <td>$17.58</td>\n   <td>33%</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td>$Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> Interactive Software(TTWO)$ Inc. TTWO</td>\n   <td>-23%</td>\n   <td>70%</td>\n   <td>$160.66</td>\n   <td>$212.87</td>\n   <td>32%</td>\n   <td>34.2</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FMC\">FMC Corp.</a> FMC</td>\n   <td>-18%</td>\n   <td>75%</td>\n   <td>$92.90</td>\n   <td>$122.89</td>\n   <td>32%</td>\n   <td>12.8</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/VRTX\">Vertex Pharmaceuticals</a> Inc. VRTX</td>\n   <td>-15%</td>\n   <td>78%</td>\n   <td>$201.33</td>\n   <td>$262.14</td>\n   <td>30%</td>\n   <td>16.2</td>\n  </tr>\n  <tr>\n   <td>Newmont Corp. NEM</td>\n   <td>-3%</td>\n   <td>71%</td>\n   <td>$56.91</td>\n   <td>$73.57</td>\n   <td>29%</td>\n   <td>16.3</td>\n  </tr>\n  <tr>\n   <td>Lamb Weston Holdings Inc. LW</td>\n   <td>-15%</td>\n   <td>78%</td>\n   <td>$66.09</td>\n   <td>$85.43</td>\n   <td>29%</td>\n   <td>26.5</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a> Inc. QCOM</td>\n   <td>-5%</td>\n   <td>64%</td>\n   <td>$143.87</td>\n   <td>$184.15</td>\n   <td>28%</td>\n   <td>15.9</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FIS\">Fidelity National Information</a> Services Inc. FIS</td>\n   <td>-8%</td>\n   <td>69%</td>\n   <td>$130.01</td>\n   <td>$165.93</td>\n   <td>28%</td>\n   <td>18.3</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/PENN\">Penn National Gaming</a> Inc. PENN</td>\n   <td>-7%</td>\n   <td>67%</td>\n   <td>$79.92</td>\n   <td>$101.50</td>\n   <td>27%</td>\n   <td>26.3</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/BAX\">Baxter</a> International Inc. BAX</td>\n   <td>-7%</td>\n   <td>53%</td>\n   <td>$73.80</td>\n   <td>$92.56</td>\n   <td>25%</td>\n   <td>19.5</td>\n  </tr>\n  <tr>\n   <td>V.F. Corp. VFC</td>\n   <td>-9%</td>\n   <td>68%</td>\n   <td>$77.06</td>\n   <td>$96.59</td>\n   <td>25%</td>\n   <td>23.1</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/ZBH\">Zimmer Biomet Holdings Inc</a>. ZBH</td>\n   <td>-2%</td>\n   <td>79%</td>\n   <td>$150.39</td>\n   <td>$187.58</td>\n   <td>25%</td>\n   <td>18.1</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/STZ\">Constellation Brands Inc</a>. Class A STZ</td>\n   <td>-1%</td>\n   <td>71%</td>\n   <td>$214.98</td>\n   <td>$265.86</td>\n   <td>24%</td>\n   <td>20.6</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/WYNN\">Wynn</a> Resorts Ltd. WYNN</td>\n   <td>-11%</td>\n   <td>54%</td>\n   <td>$100.84</td>\n   <td>$123.45</td>\n   <td>22%</td>\n   <td>N/A</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/EA\">Electronic Arts</a> Inc. EA</td>\n   <td>-1%</td>\n   <td>72%</td>\n   <td>$141.86</td>\n   <td>$172.75</td>\n   <td>22%</td>\n   <td>20.4</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>You can click on the tickers for more about each company.</p>\n<p>The list is meant to provide information -- it is not investment advice. Here's some advice: If you see any stock of interest here, do your own research to form your own opinion about the company's strategy and its long-term prospects.</p>\n<p>Market-cap weighting is less important this year</p>\n<p>The S&amp;P 500 is weighted by market capitalization, which means its performance can be dominated by the largest stocks in the index.</p>\n<p>The SPDR S&amp;P 500 ETF <a href=\"https://laohu8.com/S/SPY.AU\">$(SPY.AU)$</a> tracks the benchmark index by holding shares of all 500 companies and charging nominal annual fees totaling 0.09% of assets. Its five largest holdings (including two common-share classes for <a href=\"https://laohu8.com/S/GOOG\">Alphabet</a> Inc. <a href=\"https://laohu8.com/S/GOOGL\">$(GOOGL)$</a>(GOOGL)) make up 22.6% of the portfolio. Here's how they have performed:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Company</td>\n   <td>Total return -- 2021</td>\n   <td>Total return -- 2020</td>\n   <td>Total return -- 2019</td>\n   <td>Total return -- 3 Years</td>\n   <td>Total return -- 5 Years</td>\n   <td>% of SPY portfolio</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc. AAPL</td>\n   <td>12.3%</td>\n   <td>82%</td>\n   <td>89%</td>\n   <td>183.4%</td>\n   <td>488.3%</td>\n   <td>6.2%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> Corp MSFT.</td>\n   <td>36.7%</td>\n   <td>43%</td>\n   <td>58%</td>\n   <td>188.9%</td>\n   <td>461.1%</td>\n   <td>6.0%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/AMZN\">Amazon.com</a> Inc. AMZN</td>\n   <td>1.3%</td>\n   <td>76%</td>\n   <td>23%</td>\n   <td>73.1%</td>\n   <td>334.5%</td>\n   <td>3.7%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc. Class A</td>\n   <td>34.9%</td>\n   <td>33%</td>\n   <td>57%</td>\n   <td>110.9%</td>\n   <td>197.4%</td>\n   <td>2.3%</td>\n  </tr>\n  <tr>\n   <td><a href=\"https://laohu8.com/S/GOOGL\">Alphabet</a> Inc. Class A GOOGL</td>\n   <td>62.1%</td>\n   <td>31%</td>\n   <td>28%</td>\n   <td>129.8%</td>\n   <td>259.1%</td>\n   <td>2.2%</td>\n  </tr>\n  <tr>\n   <td>Alphabet Inc. Class C GOOG</td>\n   <td>63.2%</td>\n   <td>31%</td>\n   <td>29%</td>\n   <td>134.2%</td>\n   <td>271.6%</td>\n   <td>2.1%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>A very good 2021 so far, but you can see that Apple Inc. <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> and especially Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> have underperformed the index this year.</p>\n<p>This brings up another fascinating development related to cap-weighting that underscores how widespread good stock performance has been during 2021. This year, the <a href=\"https://laohu8.com/S/IVZ\">Invesco</a> S&amp;P 500 Equal Weight ETF <a href=\"https://laohu8.com/S/RSP\">$(RSP)$</a> has outperformed SPY and the S&amp;P 500:</p>\n<p>The weighted forward P/E ratio for the S&amp;P 500 is 21.1, according to FactSet. For comparison, the Invesco S&amp;P 500 Equal Weight ETF (RSP) has a forward P/E is 18.4.</p>\n<p>The equal-weighted approach is, arguably, less risky than the cap-weighted approach, because an investor avoids such a large concentration in a handful of stocks. But during the S&amp;P 500's strong run in recent years, the equal-weighted portfolio has underperformed the index. Here are average annual returns for various periods:</p>\n<table>\n <tbody>\n  <tr>\n   <td>Fund or index</td>\n   <td>Average return -- 3 years</td>\n   <td>Average return -- 5 years</td>\n   <td>Average return -- 10 years</td>\n   <td>Average return -- 15 years</td>\n   <td>Average return -- 17 years</td>\n  </tr>\n  <tr>\n   <td>Invesco S&amp;P 500 Equal Weight ETF RSP</td>\n   <td>15.7%</td>\n   <td>15.2%</td>\n   <td>15.7%</td>\n   <td>10.8%</td>\n   <td>11.0%</td>\n  </tr>\n  <tr>\n   <td>SPDR S&amp;P 500 ETF Trust SPY</td>\n   <td>18.1%</td>\n   <td>17.8%</td>\n   <td>16.7%</td>\n   <td>10.8%</td>\n   <td>10.7%</td>\n  </tr>\n  <tr>\n   <td>S&amp;P 500 SPX</td>\n   <td>18.2%</td>\n   <td>17.9%</td>\n   <td>16.9%</td>\n   <td>10.9%</td>\n   <td>10.8%</td>\n  </tr>\n  <tr>\n   <td>Source: FactSet</td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n   <td></td>\n  </tr>\n </tbody>\n</table>\n<p>RSP was established in August 2003, so the longest period for the average returns shown above is 17 years. For that period, the equal-weighed has approach performed best, while it has underperformed the cap-weighted index in all the more recent periods. Click here for Mark Hulbert's analysis of the weighted vs. unweighted approaches going back to 1970.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SPY":"标普500ETF","MU":"美光科技","OEF":"标普100指数ETF-iShares","VRTX":"福泰制药","OEX":"标普100","ATVI":"动视暴雪","SSO":"两倍做多标普500ETF","SDS":"两倍做空标普500ETF","UPRO":"三倍做多标普500ETF","SPXU":"三倍做空标普500ETF","TTWO":"Take-Two Interactive Software","NEM":"纽曼矿业","SH":"标普500反向ETF","IVV":"标普500指数ETF",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162018921","content_text":"Some surprises among the small number of stocks that are down for 2021\nThe S&P 500 index closed at another all-time high on Wednesday, its 51st record this year. Success has been widespread, with 250 of the S&P 500 outperforming the index as a whole. But there are always some stocks left behind, including the list of highly regarded names below.\nFirst, consider how well the S&P 500 has been performing. It was up 20.8% for 2021 through Aug. 25, with dividends reinvested. That follows returns of 32.5% in 2020 and 31.5% in 2019. The index has returned 88.1% since the end of 2018. All performance figures in this article include reinvested dividends.\nIf we even out the numbers, the S&P 500 has returned 65% for three years, 128% for five years and 375% for 10 years, underlining the case for stocks as the ideal asset class for most long-term investors. Performance slips if we go out 15 years to cover the 2008 financial crisis, with a return of 367%.\nStocks left behind in 2021 that may have great potential for investors\nThrough Aug. 25, 58 of the S&P 500 components were down for 2021. Among those stocks, 33 have majority \"buy\" ratings among analysts polled by FactSet. Here are the 20 that the analysts expect to perform the best over the next 12 months, along with their forward price-to-earnings ratios:\n\n\n\nCompany\nTotal return -- 2021\nShare \"buy\" ratings\nClosing price -- Aug. 25\nConsensus price target\nImplied 12-month upside potential\nForward P/E\n\n\nMicron Technology Inc. MU\n-2%\n85%\n$74.04\n$117.79\n59%\n7.0\n\n\nLas Vegas Sands Corp. LVS\n-27%\n63%\n$43.24\n$64.38\n49%\n44.7\n\n\nActivision Blizzard Inc. ATVI\n-13%\n91%\n$80.81\n$116.04\n44%\n21.1\n\n\nGlobal Payments Inc. GPN\n-23%\n81%\n$165.25\n$228.69\n38%\n18.6\n\n\nIncyte Corp. INCY\n-13%\n60%\n$75.76\n$102.47\n35%\n32.2\n\n\nNOV Inc. NOV\n-3%\n59%\n$13.26\n$17.58\n33%\nN/A\n\n\n$Take-Two Interactive Software(TTWO)$ Inc. TTWO\n-23%\n70%\n$160.66\n$212.87\n32%\n34.2\n\n\nFMC Corp. FMC\n-18%\n75%\n$92.90\n$122.89\n32%\n12.8\n\n\nVertex Pharmaceuticals Inc. VRTX\n-15%\n78%\n$201.33\n$262.14\n30%\n16.2\n\n\nNewmont Corp. NEM\n-3%\n71%\n$56.91\n$73.57\n29%\n16.3\n\n\nLamb Weston Holdings Inc. LW\n-15%\n78%\n$66.09\n$85.43\n29%\n26.5\n\n\nQualcomm Inc. QCOM\n-5%\n64%\n$143.87\n$184.15\n28%\n15.9\n\n\nFidelity National Information Services Inc. FIS\n-8%\n69%\n$130.01\n$165.93\n28%\n18.3\n\n\nPenn National Gaming Inc. PENN\n-7%\n67%\n$79.92\n$101.50\n27%\n26.3\n\n\nBaxter International Inc. BAX\n-7%\n53%\n$73.80\n$92.56\n25%\n19.5\n\n\nV.F. Corp. VFC\n-9%\n68%\n$77.06\n$96.59\n25%\n23.1\n\n\nZimmer Biomet Holdings Inc. ZBH\n-2%\n79%\n$150.39\n$187.58\n25%\n18.1\n\n\nConstellation Brands Inc. Class A STZ\n-1%\n71%\n$214.98\n$265.86\n24%\n20.6\n\n\nWynn Resorts Ltd. WYNN\n-11%\n54%\n$100.84\n$123.45\n22%\nN/A\n\n\nElectronic Arts Inc. EA\n-1%\n72%\n$141.86\n$172.75\n22%\n20.4\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\n\nYou can click on the tickers for more about each company.\nThe list is meant to provide information -- it is not investment advice. Here's some advice: If you see any stock of interest here, do your own research to form your own opinion about the company's strategy and its long-term prospects.\nMarket-cap weighting is less important this year\nThe S&P 500 is weighted by market capitalization, which means its performance can be dominated by the largest stocks in the index.\nThe SPDR S&P 500 ETF $(SPY.AU)$ tracks the benchmark index by holding shares of all 500 companies and charging nominal annual fees totaling 0.09% of assets. Its five largest holdings (including two common-share classes for Alphabet Inc. $(GOOGL)$(GOOGL)) make up 22.6% of the portfolio. Here's how they have performed:\n\n\n\nCompany\nTotal return -- 2021\nTotal return -- 2020\nTotal return -- 2019\nTotal return -- 3 Years\nTotal return -- 5 Years\n% of SPY portfolio\n\n\nApple Inc. AAPL\n12.3%\n82%\n89%\n183.4%\n488.3%\n6.2%\n\n\nMicrosoft Corp MSFT.\n36.7%\n43%\n58%\n188.9%\n461.1%\n6.0%\n\n\nAmazon.com Inc. AMZN\n1.3%\n76%\n23%\n73.1%\n334.5%\n3.7%\n\n\nFacebook Inc. Class A\n34.9%\n33%\n57%\n110.9%\n197.4%\n2.3%\n\n\nAlphabet Inc. Class A GOOGL\n62.1%\n31%\n28%\n129.8%\n259.1%\n2.2%\n\n\nAlphabet Inc. Class C GOOG\n63.2%\n31%\n29%\n134.2%\n271.6%\n2.1%\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\n\nA very good 2021 so far, but you can see that Apple Inc. $(AAPL)$ and especially Amazon.com Inc. $(AMZN)$ have underperformed the index this year.\nThis brings up another fascinating development related to cap-weighting that underscores how widespread good stock performance has been during 2021. This year, the Invesco S&P 500 Equal Weight ETF $(RSP)$ has outperformed SPY and the S&P 500:\nThe weighted forward P/E ratio for the S&P 500 is 21.1, according to FactSet. For comparison, the Invesco S&P 500 Equal Weight ETF (RSP) has a forward P/E is 18.4.\nThe equal-weighted approach is, arguably, less risky than the cap-weighted approach, because an investor avoids such a large concentration in a handful of stocks. But during the S&P 500's strong run in recent years, the equal-weighted portfolio has underperformed the index. Here are average annual returns for various periods:\n\n\n\nFund or index\nAverage return -- 3 years\nAverage return -- 5 years\nAverage return -- 10 years\nAverage return -- 15 years\nAverage return -- 17 years\n\n\nInvesco S&P 500 Equal Weight ETF RSP\n15.7%\n15.2%\n15.7%\n10.8%\n11.0%\n\n\nSPDR S&P 500 ETF Trust SPY\n18.1%\n17.8%\n16.7%\n10.8%\n10.7%\n\n\nS&P 500 SPX\n18.2%\n17.9%\n16.9%\n10.9%\n10.8%\n\n\nSource: FactSet\n\n\n\n\n\n\n\n\nRSP was established in August 2003, so the longest period for the average returns shown above is 17 years. For that period, the equal-weighed has approach performed best, while it has underperformed the cap-weighted index in all the more recent periods. Click here for Mark Hulbert's analysis of the weighted vs. unweighted approaches going back to 1970.","news_type":1},"isVote":1,"tweetType":1,"viewCount":196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892048507,"gmtCreate":1628616982409,"gmtModify":1633745695303,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892048507","repostId":"2158048475","repostType":4,"isVote":1,"tweetType":1,"viewCount":26,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123545816,"gmtCreate":1624431637135,"gmtModify":1634006210755,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Good. Please help comment.tks.","listText":"Good. Please help comment.tks.","text":"Good. Please help comment.tks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/123545816","repostId":"1120218733","repostType":4,"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819480291,"gmtCreate":1630087550113,"gmtModify":1704955825153,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Great news","listText":"Great news","text":"Great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819480291","repostId":"1123342356","repostType":4,"isVote":1,"tweetType":1,"viewCount":227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897333477,"gmtCreate":1628877095199,"gmtModify":1633688806393,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Will take a look","listText":"Will take a look","text":"Will take a look","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/897333477","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","kind":"highlight","pubTimestamp":1628864400,"share":"https://www.laohu8.com/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for&nbsp;<b>Coinbase Global</b> (NASDAQ:COIN) and&nbsp;<b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range&nbsp;of products to 68 million&nbsp;users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2%&nbsp;of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson&nbsp;value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees&nbsp;comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price&nbsp;of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2020 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Monthly transacting users</p></td>\n   <td width=\"156\"><p>1.5 million</p></td>\n   <td width=\"156\"><p>8.8 million</p></td>\n   <td width=\"156\"><p>487%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Revenue</p></td>\n   <td width=\"156\"><p>$633.8 million</p></td>\n   <td width=\"156\"><p>$4.9 billion</p></td>\n   <td width=\"156\"><p>678%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase&nbsp;SEC filings. TTM&nbsp;= trailing-12-months. CAGR&nbsp;= compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built&nbsp;to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler&nbsp;value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n  <tr>\n   <th><p>Metric</p></th>\n   <th><p>Q2 2019 (TTM)</p></th>\n   <th><p>Q2 2021 (TTM)</p></th>\n   <th><p>CAGR</p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"156\"><p>Customers</p></td>\n   <td width=\"156\"><p>442,752</p></td>\n   <td width=\"156\"><p>1.2 million</p></td>\n   <td width=\"156\"><p>65%</p></td>\n  </tr>\n  <tr>\n   <td width=\"156\"><p>Gross profit</p></td>\n   <td width=\"156\"><p>$5.7 million</p></td>\n   <td width=\"156\"><p>$26.5 million</p></td>\n   <td width=\"156\"><p>116%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc.","COIN":"Coinbase Global, Inc."},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1},"isVote":1,"tweetType":1,"viewCount":205,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":897333828,"gmtCreate":1628877032664,"gmtModify":1633688806840,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Good job!","listText":"Good job!","text":"Good job!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897333828","repostId":"2159821885","repostType":4,"repost":{"id":"2159821885","kind":"news","pubTimestamp":1628865635,"share":"https://www.laohu8.com/m/news/2159821885?lang=&edition=full","pubTime":"2021-08-13 22:40","market":"us","language":"en","title":"Microsoft Could Be A Buy For Its Upcoming Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2159821885","media":"Simply Wall St.","summary":"Microsoft Corporation (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend d","content":"<p><b>Microsoft Corporation</b> (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend date is <a href=\"https://laohu8.com/S/AONE.U\">one</a> business day before the record date, which is the cut-off date for shareholders to be present on the company's books to be eligible for a dividend payment. It is important to be aware of the ex-dividend date because any trade on the stock needs to have been settled on or before the record date. Therefore, if you purchase Microsoft's shares on or after the 18th of August, you won't be eligible to receive the dividend, when it is paid on the 9th of September.</p>\n<p>The company's next dividend payment will be US$0.56 per share, and in the last 12 months, the company paid a total of US$2.24 per share. Calculating the last year's worth of payments shows that Microsoft has a trailing yield of 0.8% on the current share price of $289.81. If you buy this business for its dividend, you should have an idea of whether Microsoft's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.</p>\n<p>Check out our latest analysis for Microsoft</p>\n<p>Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Microsoft paid out a comfortable 28% of its profit last year. A useful secondary check can be to evaluate whether Microsoft generated enough free cash flow to afford its dividend. It distributed 29% of its free cash flow as dividends, a comfortable payout level for most companies.</p>\n<p>It's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.</p>\n<p>Click here to see the company's payout ratio, plus analyst estimates of its future dividends.</p>\n<p class=\"t-img-caption\"><img src=\"https://s.yimg.com/uu/api/res/1.2/BdBRcdx9GWAsYwcOGwlNPA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/simply_wall_st__316/879002c79492bbd3bb1260ed6a40a52f\" tg-width=\"821\" tg-height=\"508\" width=\"100%\" height=\"auto\"><span>NasdaqGS:MSFT Historic Dividend August 13th 2021</span></p>\n<h3>Have Earnings And Dividends Been Growing?</h3>\n<p>Companies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If earnings fall far enough, the company could be forced to cut its dividend. It's encouraging to see Microsoft has grown its earnings rapidly, up 26% a year for the past five years. Microsoft is paying out less than half its earnings and cash flow, while simultaneously growing earnings per share at a rapid clip. Companies with growing earnings and low payout ratios are often the best long-term dividend stocks, as the company can both grow its earnings and increase the percentage of earnings that it pays out, essentially multiplying the dividend.</p>\n<p>The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Microsoft has increased its dividend at approximately 13% a year on average. It's exciting to see that both earnings and dividends per share have grown rapidly over the past few years.</p>\n<h3>The Bottom Line</h3>\n<p>Has Microsoft got what it takes to maintain its dividend payments? We love that Microsoft is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. These characteristics suggest the company is reinvesting in growing its business, while the conservative payout ratio also implies a reduced risk of the dividend being cut in the future. It's a promising combination that should mark this company worthy of closer attention.</p>\n<p>While it's tempting to invest in Microsoft for the dividends alone, you should always be mindful of the risks involved. For example - Microsoft has <b>1 warning sign</b> we think you should be aware of.</p>\n<p>A common investment mistake is buying the first interesting stock you see. Here you can find a list of promising dividend stocks with a greater than 2% yield and an upcoming dividend.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft Could Be A Buy For Its Upcoming Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft Could Be A Buy For Its Upcoming Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/microsoft-nasdaq-msft-could-buy-085435825.html><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Microsoft Corporation (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be ...</p>\n\n<a href=\"https://finance.yahoo.com/news/microsoft-nasdaq-msft-could-buy-085435825.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"source_url":"https://finance.yahoo.com/news/microsoft-nasdaq-msft-could-buy-085435825.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2159821885","content_text":"Microsoft Corporation (NASDAQ:MSFT) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be present on the company's books to be eligible for a dividend payment. It is important to be aware of the ex-dividend date because any trade on the stock needs to have been settled on or before the record date. Therefore, if you purchase Microsoft's shares on or after the 18th of August, you won't be eligible to receive the dividend, when it is paid on the 9th of September.\nThe company's next dividend payment will be US$0.56 per share, and in the last 12 months, the company paid a total of US$2.24 per share. Calculating the last year's worth of payments shows that Microsoft has a trailing yield of 0.8% on the current share price of $289.81. If you buy this business for its dividend, you should have an idea of whether Microsoft's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.\nCheck out our latest analysis for Microsoft\nDividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Microsoft paid out a comfortable 28% of its profit last year. A useful secondary check can be to evaluate whether Microsoft generated enough free cash flow to afford its dividend. It distributed 29% of its free cash flow as dividends, a comfortable payout level for most companies.\nIt's encouraging to see that the dividend is covered by both profit and cash flow. This generally suggests the dividend is sustainable, as long as earnings don't drop precipitously.\nClick here to see the company's payout ratio, plus analyst estimates of its future dividends.\nNasdaqGS:MSFT Historic Dividend August 13th 2021\nHave Earnings And Dividends Been Growing?\nCompanies with consistently growing earnings per share generally make the best dividend stocks, as they usually find it easier to grow dividends per share. If earnings fall far enough, the company could be forced to cut its dividend. It's encouraging to see Microsoft has grown its earnings rapidly, up 26% a year for the past five years. Microsoft is paying out less than half its earnings and cash flow, while simultaneously growing earnings per share at a rapid clip. Companies with growing earnings and low payout ratios are often the best long-term dividend stocks, as the company can both grow its earnings and increase the percentage of earnings that it pays out, essentially multiplying the dividend.\nThe main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. In the past 10 years, Microsoft has increased its dividend at approximately 13% a year on average. It's exciting to see that both earnings and dividends per share have grown rapidly over the past few years.\nThe Bottom Line\nHas Microsoft got what it takes to maintain its dividend payments? We love that Microsoft is growing earnings per share while simultaneously paying out a low percentage of both its earnings and cash flow. These characteristics suggest the company is reinvesting in growing its business, while the conservative payout ratio also implies a reduced risk of the dividend being cut in the future. It's a promising combination that should mark this company worthy of closer attention.\nWhile it's tempting to invest in Microsoft for the dividends alone, you should always be mindful of the risks involved. For example - Microsoft has 1 warning sign we think you should be aware of.\nA common investment mistake is buying the first interesting stock you see. Here you can find a list of promising dividend stocks with a greater than 2% yield and an upcoming dividend.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892048448,"gmtCreate":1628617046884,"gmtModify":1633745695180,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Go apple go","listText":"Go apple go","text":"Go apple go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/892048448","repostId":"1160585513","repostType":4,"repost":{"id":"1160585513","kind":"news","pubTimestamp":1628597037,"share":"https://www.laohu8.com/m/news/1160585513?lang=&edition=full","pubTime":"2021-08-10 20:03","market":"us","language":"en","title":"Apple Readies New iPhones With Pro-Focused Camera, Video Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=1160585513","media":"Bloomberg","summary":"Apple Inc.’s next iPhone lineup will get at least three major new camera and video-recording features, which the company is betting will be key enticements to upgrade from earlier models.The new handsets will include a video version of the phone’s Portrait mode feature, the ability to record video in a higher-quality format called ProRes, and a new filters-like system that improves the look and colors of photos, according to people familiar with the matter. The camera features are seen as some o","content":"<p>Apple Inc.’s next iPhone lineup will get at least three major new camera and video-recording features, which the company is betting will be key enticements to upgrade from earlier models.</p>\n<p>The new handsets will include a video version of the phone’s Portrait mode feature, the ability to record video in a higher-quality format called ProRes, and a new filters-like system that improves the look and colors of photos, according to people familiar with the matter. The camera features are seen as some of the biggest selling points for the iPhone 12’s successor, which is expected to go on sale in the next several weeks.</p>\n<p>Beyond the camera enhancements, the new iPhones will get relatively modest upgrades. Last year, Apple revamped the iPhone design, added 5G wireless networking and updated the camera hardware. For this year, the company will retain the same 5.4-inch and 6.1-inch regular sizes and 6.1-inch and 6.7-inch Pro screen dimensions, as well as their designs.</p>\n<p>The new phones will include a faster A15 chip and a smaller notch, also known as the display cutout, in addition to new screen technology that could enable a faster refresh rate for smoother scrolling.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0af5c87c6513ff6750254db4601d56b4\" tg-width=\"400\" tg-height=\"224\" referrerpolicy=\"no-referrer\"><span>Portrait mode during a FaceTime video call.Source: Apple Inc.</span></p>\n<p>The Cupertino, California-based company typically unveils its new iPhones in September, but last year’s launch was delayed until October due to production complications stemming from Covid-19. With Apple nowpushing backits office return by several weeks, the company’s next iPhone launch is likely to be virtual. An Apple spokeswoman declined to comment.</p>\n<p>Apple first added Portrait mode to the iPhone 7 Plus in 2016, and it quickly become a fan favorite. The feature can put a person in sharp focus while blurring the background in what is known as a bokeh effect. For the new iPhones, Apple plans to add this same technique to video with a feature internally dubbed Cinematic Video. Like with still photos, the iPhone’s depth sensor will create the effect and allow users to change the amount of blur after recording.</p>\n<p>A new ProRes video-recording feature will let iPhone users capture clips in a higher-quality format that gives editors more control during post-production.</p>\n<p>The format is used by professional video editors in the film industry and isn’t normally intended for the mass market in part because of its large file sizes. ProRes will record in either HD and 4K resolutions on the next iPhones.</p>\n<p>The ProRes feature would follow last year’s addition of ProRAW, a higher-quality still photo file format that gives professional editors more control. Like with ProRAW, the ProRes video recording may be exclusive to the pricier Pro models.</p>\n<p>Another feature will let users better control the look of colors and highlights in their pictures. Users will be able to choose from several styles to apply to their photos, including one for showing colors at either a warmer or cooler temperature while keeping whites neutral. Another option will add a more dramatic look with deeper shadows and more contrast, and the company is planning a more balanced style for showing shadows and true-to-life colors with a brighter appearance.</p>\n<p>The feature will differ from standard filters, available in the iPhone’s Camera app since 2013, by precisely applying changes to objects and people across the photos using artificial intelligence, rather than applying a single filter across the entire picture.</p>\n<p>Apple’s new iPhones, codenamed D16, D17, D63 and D64, are just a few of the new devices poised to launch in the coming months. The company is also working onrevamped MacBook Proswith in-house chips likely to be dubbed M1X, aredesigned iPad miniand an entry-level iPad geared at students. It’s also preparing newApple Watchesandentry-level AirPods.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Readies New iPhones With Pro-Focused Camera, Video Updates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Readies New iPhones With Pro-Focused Camera, Video Updates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-10 20:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-10/apple-readies-new-iphones-with-pro-focused-camera-video-updates><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple Inc.’s next iPhone lineup will get at least three major new camera and video-recording features, which the company is betting will be key enticements to upgrade from earlier models.\nThe new ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-10/apple-readies-new-iphones-with-pro-focused-camera-video-updates\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.bloomberg.com/news/articles/2021-08-10/apple-readies-new-iphones-with-pro-focused-camera-video-updates","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160585513","content_text":"Apple Inc.’s next iPhone lineup will get at least three major new camera and video-recording features, which the company is betting will be key enticements to upgrade from earlier models.\nThe new handsets will include a video version of the phone’s Portrait mode feature, the ability to record video in a higher-quality format called ProRes, and a new filters-like system that improves the look and colors of photos, according to people familiar with the matter. The camera features are seen as some of the biggest selling points for the iPhone 12’s successor, which is expected to go on sale in the next several weeks.\nBeyond the camera enhancements, the new iPhones will get relatively modest upgrades. Last year, Apple revamped the iPhone design, added 5G wireless networking and updated the camera hardware. For this year, the company will retain the same 5.4-inch and 6.1-inch regular sizes and 6.1-inch and 6.7-inch Pro screen dimensions, as well as their designs.\nThe new phones will include a faster A15 chip and a smaller notch, also known as the display cutout, in addition to new screen technology that could enable a faster refresh rate for smoother scrolling.\nPortrait mode during a FaceTime video call.Source: Apple Inc.\nThe Cupertino, California-based company typically unveils its new iPhones in September, but last year’s launch was delayed until October due to production complications stemming from Covid-19. With Apple nowpushing backits office return by several weeks, the company’s next iPhone launch is likely to be virtual. An Apple spokeswoman declined to comment.\nApple first added Portrait mode to the iPhone 7 Plus in 2016, and it quickly become a fan favorite. The feature can put a person in sharp focus while blurring the background in what is known as a bokeh effect. For the new iPhones, Apple plans to add this same technique to video with a feature internally dubbed Cinematic Video. Like with still photos, the iPhone’s depth sensor will create the effect and allow users to change the amount of blur after recording.\nA new ProRes video-recording feature will let iPhone users capture clips in a higher-quality format that gives editors more control during post-production.\nThe format is used by professional video editors in the film industry and isn’t normally intended for the mass market in part because of its large file sizes. ProRes will record in either HD and 4K resolutions on the next iPhones.\nThe ProRes feature would follow last year’s addition of ProRAW, a higher-quality still photo file format that gives professional editors more control. Like with ProRAW, the ProRes video recording may be exclusive to the pricier Pro models.\nAnother feature will let users better control the look of colors and highlights in their pictures. Users will be able to choose from several styles to apply to their photos, including one for showing colors at either a warmer or cooler temperature while keeping whites neutral. Another option will add a more dramatic look with deeper shadows and more contrast, and the company is planning a more balanced style for showing shadows and true-to-life colors with a brighter appearance.\nThe feature will differ from standard filters, available in the iPhone’s Camera app since 2013, by precisely applying changes to objects and people across the photos using artificial intelligence, rather than applying a single filter across the entire picture.\nApple’s new iPhones, codenamed D16, D17, D63 and D64, are just a few of the new devices poised to launch in the coming months. The company is also working onrevamped MacBook Proswith in-house chips likely to be dubbed M1X, aredesigned iPad miniand an entry-level iPad geared at students. It’s also preparing newApple Watchesandentry-level AirPods.","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892048809,"gmtCreate":1628616876701,"gmtModify":1633745695424,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/892048809","repostId":"1181860181","repostType":4,"repost":{"id":"1181860181","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628603123,"share":"https://www.laohu8.com/m/news/1181860181?lang=&edition=full","pubTime":"2021-08-10 21:45","market":"us","language":"en","title":"Novavax shares jumped nearly 12% in early trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1181860181","media":"Tiger Newspress","summary":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the th","content":"<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p>\n<p>The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p>\n<p>The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p>\n<p>Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares jumped nearly 12% in early trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares jumped nearly 12% in early trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-10 21:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;12%&nbsp;in&nbsp;early&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e7eaa88109e0546c102a9f6dcce84c43\" tg-width=\"849\" tg-height=\"606\" referrerpolicy=\"no-referrer\">The&nbsp;New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported&nbsp;Barron's.</p>\n<p>The pension also doubled its investment in COVID-19 vaccine play&nbsp;Moderna Inc&nbsp;.</p>\n<p>The retirement fund also initiated a position in&nbsp;BioNTech SE&nbsp;, the German COVID-19 vaccine partner of&nbsp;Pfizer Inc.</p>\n<p>Also on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181860181","content_text":"Novavax shares jumped nearly 12% in early trading.\nThe New York State Common Retirement Fund, the third-largest public pension in the United States, increased its exposure to Novavax shares,reported Barron's.\nThe pension also doubled its investment in COVID-19 vaccine play Moderna Inc .\nThe retirement fund also initiated a position in BioNTech SE , the German COVID-19 vaccine partner of Pfizer Inc.\nAlso on Monday, the Philippines’ Food and Drug Administration began evaluating Novavax’s application for emergency use authorization for its COVID-19 vaccine, as per areportfrom the Manila Bulletin.","news_type":1},"isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":129443536,"gmtCreate":1624383706825,"gmtModify":1634006905996,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Good. Keep it up","listText":"Good. Keep it up","text":"Good. Keep it up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/129443536","repostId":"1163697674","repostType":4,"repost":{"id":"1163697674","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624370501,"share":"https://www.laohu8.com/m/news/1163697674?lang=&edition=full","pubTime":"2021-06-22 22:01","market":"us","language":"en","title":"Clover Health rally Tuesday, rose over 17% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1163697674","media":"Tiger Newspress","summary":"(June 22) Clover Health rally Tuesday, rose over 17% in morning trading.","content":"<p>(June 22)&nbsp;Clover Health rally Tuesday, rose over 17% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/c8220041ca1b41ddcd04ef608958edf3\" tg-width=\"658\" tg-height=\"477\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Clover Health rally Tuesday, rose over 17% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nClover Health rally Tuesday, rose over 17% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-22 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 22)&nbsp;Clover Health rally Tuesday, rose over 17% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/c8220041ca1b41ddcd04ef608958edf3\" tg-width=\"658\" tg-height=\"477\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163697674","content_text":"(June 22) Clover Health rally Tuesday, rose over 17% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":96,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819489817,"gmtCreate":1630087728639,"gmtModify":1704955826188,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Anyoneb uying?","listText":"Anyoneb uying?","text":"Anyoneb uying?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/819489817","repostId":"2162602132","repostType":4,"repost":{"id":"2162602132","kind":"highlight","pubTimestamp":1630076857,"share":"https://www.laohu8.com/m/news/2162602132?lang=&edition=full","pubTime":"2021-08-27 23:07","market":"us","language":"en","title":"Which Biotech Stock Will Shock the Market in 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=2162602132","media":"Motley Fool","summary":"Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?","content":"<p>In 2019, tiny&nbsp;<b><a href=\"https://laohu8.com/S/AXSM\">Axsome Therapeutics</a>&nbsp;</b>(NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech,&nbsp;<b><a href=\"https://laohu8.com/S/NVAX\">Novavax</a>&nbsp;</b>(NASDAQ:NVAX), came out of nowhere to stomp the stock market, with its share price skyrocketing by 2,700%. For most of 2021, yet another small biotech has been the top-performing stock in the market, as&nbsp;<b><a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a> </b>(NASDAQ:SAVA) jumped from under $7 a share in January to $123 a share on Aug. 24. (Whether it will keep its lead is another question, as the volatility is savage -- the stock is down to $52 as of Friday morning after news of a citizen petition against the company.)</p>\n<p>What's fascinating about the biotech sector in particular is how fast it moves. The sector is notorious for amazing price swings -- in either direction -- that can happen overnight. So why is that? Why are biotech stocks in particular so volatile? Why do they keep leading the market every year? And what biotech stock might -- repeat, <i>might&nbsp;</i>-- pull off this feat next year? Let's analyze why Axsome, Novavax, and Cassava zoomed higher over the last few years, and why I think <b><a href=\"https://laohu8.com/S/PIRS\">Pieris Pharmaceuticals</a> </b>(NASDAQ:PIRS) has a chance at a similar remarkable performance in 2022.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F638648%2Fgettyimages-108224060.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"465\" referrerpolicy=\"no-referrer\"></p>\n<h2>Biotech winners tend to start off tiny</h2>\n<p>The main reason these stocks were able to soar so impressively is that all three started with very tiny market caps. At the end of 2018, Axsome Therapeutics had a micro-cap valuation of $85 million. In 2019, Novavax stock fell to below $1, and the company had to do a 1-for-20 reverse split in order to keep its shares listed on the <b><a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a></b>. And at the beginning of 2020, Cassava had barely achieved small-cap status, with its market cap hovering at $240 million.</p>\n<p>So all three barn-burning stocks started off unloved by the market. Why does a biotech stock get so cheap? Probably the most common reason is the market believes the company's science is bad. Novavax, for instance, had a notable failure in its quest for a respiratory syncytial virus (RSV) vaccine. This clinical trial failure sent investors to the exits and sent the stock down into a crater in 2019, when it plunged to $4 a share (or $0.20 pre-split).</p>\n<p>Yet the market was spectacularly wrong about Novavax. While the company's RSV drug was a failure, Novavax had another drug in clinical trials, a flu vaccine. And this drug was a world-beater. It was flying through clinical trials, and it had defeated the market-leading flu vaccines from <b><a href=\"https://laohu8.com/S/SNY\">Sanofi SA</a></b>&nbsp;(NASDAQ:SNY) over and over again.</p>\n<p>In 2019, Novavax had the label of \"bad science,\" but the data for a different drug said otherwise. Sometimes companies with tiny market caps actually have compelling drugs that are performing exceptionally well in clinical trials. If you find such a company, you might want to buy some shares.</p>\n<h2>Is there enough money for a phase 3 trial?</h2>\n<p>That said, it's not enough just to have good science. Nobody is allowed to market their drugs to the public until that science has been validated in clinical trials and approved by the U.S. Food and Drug Administration -- and clinical trials cost a huge amount of money. Thus, before investing, it's important to determine whether the biotech has enough cash for a phase 3 trial. If the answer is \"no,\" the drug is stalled and won't go anywhere.</p>\n<p>Many unprofitable biotech companies finesse the money issue by collaborating with Big Pharma. When you see such a collaboration, you can have faith that there's enough cash for a phase 3 trial. However, these arrangements also often mean that the bigger pharmaceutical company acquires the rights to the molecule. And that can be like like selling off your future in order to pay the bills today.</p>\n<p>Interestingly, neither Axsome nor Novavax nor Cassava have an active collaboration with any big-pharma leaders. Instead, all three of these companies have elected to own 100% of the rights to their lead molecules. While the median expense for a phase 3 trial is $19 million, the numbers can vary dramatically, depending on how large the patient population is. I'd be nervous if a biotech had less than $100 million in cash (each of these has more). There's no question this independent approach is riskier, but also potentially a lot more rewarding.</p>\n<p>Biotech investors often like to see collaboration with Big Pharma -- it's a validation of the science, and it removes a lot of financial worries for small companies. But if you're chasing big rewards, you might want to look at biotech companies that are still independent (and have enough cash to stay that way).</p>\n<h2>Can Pieris pull off a miracle run in 2022?</h2>\n<p>Pieris stock is very cheap right now, with a $291 million valuation. (You know a stock is cheap when it could have a 10-bagger and still qualify as a small-cap!) Is the stock so cheap because its science is bad?</p>\n<p>It would probably be more accurate to say that Pieris' science is unproven. Like many unprofitable biotechs, Pieris doesn't have a drug in phase 3 trials yet. In fact, we're still waiting on positive phase 2 data. So it's early, and that's a danger sign. The reason Axsome, Novavax, and Cassava all skyrocketed is that all three companies made the journey from unproven drug to pivotal trials very quickly. Pieris is a few years away.</p>\n<p>Another major difference is that Pieris has signed multiple collaborative deals -- with <b>Roche</b>, <b>AstraZeneca</b>, and <b>Seagen</b>, among others. In <a href=\"https://laohu8.com/S/AONE.U\">one</a> sense that's good news, because it means that money for clinical trials isn't an issue for the company. Any drugs that work will make it to phase 3 trials and beyond. And all this collaboration adds confidence that the company is on the right track.</p>\n<p>Is Pieris sacrificing its future to pay for its present? In my opinion, no. While AstraZeneca now has rights to the company's asthma drug (its lead molecule), what makes Pieris such an exciting stock is not <a href=\"https://laohu8.com/S/AONE.U\">one</a> particular drug, but the company's entire platform. Pieris owns the rights to all the Anticalin proteins, and its library contains more than 100 billion of these new molecules. Anticalins are much smaller than antibodies, and as such can go where antibodies cannot. AstraZeneca paid big bucks for the rights to Pieris' asthma drug because that Anticalin molecule is small enough to go directly to the lung.</p>\n<p>I love the risk/reward equation for Pieris. If the company's drugs actually work -- we'll have data in that regard next year -- the stock will shoot much higher. Under its existing collaboration agreements, Pieris might make up to $9 billion if its Anticalin drugs reach certain milestones.&nbsp;But what will really make the stock take off is if/when other pharmaceutical players start making deals to add some of the company's Anticalin molecules to their pipelines.</p>\n<p>How do you value an entire new class of pharmaceuticals? Well, in 2019, worldwide sales for monoclonal antibodies (mAbs) totaled <i>$163 billion</i>. If Pieris' partners report any positive data on its Anticalin drugs next year, the upside for this stock is enormous.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Which Biotech Stock Will Shock the Market in 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhich Biotech Stock Will Shock the Market in 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 23:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In 2019, tiny Axsome Therapeutics (NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AXSM":"Axsome Therapeutics, Inc.","NVAX":"诺瓦瓦克斯医药","SAVA":"Cassava Sciences Inc"},"source_url":"https://www.fool.com/investing/2021/08/27/which-biotech-stock-will-shock-the-market-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162602132","content_text":"In 2019, tiny Axsome Therapeutics (NASDAQ:AXSM) emerged from micro-cap obscurity to become the best-performing stock in the market, rising by an amazing 3,600% in a year. In 2020, another tiny biotech, Novavax (NASDAQ:NVAX), came out of nowhere to stomp the stock market, with its share price skyrocketing by 2,700%. For most of 2021, yet another small biotech has been the top-performing stock in the market, as Cassava Sciences Inc (NASDAQ:SAVA) jumped from under $7 a share in January to $123 a share on Aug. 24. (Whether it will keep its lead is another question, as the volatility is savage -- the stock is down to $52 as of Friday morning after news of a citizen petition against the company.)\nWhat's fascinating about the biotech sector in particular is how fast it moves. The sector is notorious for amazing price swings -- in either direction -- that can happen overnight. So why is that? Why are biotech stocks in particular so volatile? Why do they keep leading the market every year? And what biotech stock might -- repeat, might -- pull off this feat next year? Let's analyze why Axsome, Novavax, and Cassava zoomed higher over the last few years, and why I think Pieris Pharmaceuticals (NASDAQ:PIRS) has a chance at a similar remarkable performance in 2022.\n\nBiotech winners tend to start off tiny\nThe main reason these stocks were able to soar so impressively is that all three started with very tiny market caps. At the end of 2018, Axsome Therapeutics had a micro-cap valuation of $85 million. In 2019, Novavax stock fell to below $1, and the company had to do a 1-for-20 reverse split in order to keep its shares listed on the Nasdaq. And at the beginning of 2020, Cassava had barely achieved small-cap status, with its market cap hovering at $240 million.\nSo all three barn-burning stocks started off unloved by the market. Why does a biotech stock get so cheap? Probably the most common reason is the market believes the company's science is bad. Novavax, for instance, had a notable failure in its quest for a respiratory syncytial virus (RSV) vaccine. This clinical trial failure sent investors to the exits and sent the stock down into a crater in 2019, when it plunged to $4 a share (or $0.20 pre-split).\nYet the market was spectacularly wrong about Novavax. While the company's RSV drug was a failure, Novavax had another drug in clinical trials, a flu vaccine. And this drug was a world-beater. It was flying through clinical trials, and it had defeated the market-leading flu vaccines from Sanofi SA (NASDAQ:SNY) over and over again.\nIn 2019, Novavax had the label of \"bad science,\" but the data for a different drug said otherwise. Sometimes companies with tiny market caps actually have compelling drugs that are performing exceptionally well in clinical trials. If you find such a company, you might want to buy some shares.\nIs there enough money for a phase 3 trial?\nThat said, it's not enough just to have good science. Nobody is allowed to market their drugs to the public until that science has been validated in clinical trials and approved by the U.S. Food and Drug Administration -- and clinical trials cost a huge amount of money. Thus, before investing, it's important to determine whether the biotech has enough cash for a phase 3 trial. If the answer is \"no,\" the drug is stalled and won't go anywhere.\nMany unprofitable biotech companies finesse the money issue by collaborating with Big Pharma. When you see such a collaboration, you can have faith that there's enough cash for a phase 3 trial. However, these arrangements also often mean that the bigger pharmaceutical company acquires the rights to the molecule. And that can be like like selling off your future in order to pay the bills today.\nInterestingly, neither Axsome nor Novavax nor Cassava have an active collaboration with any big-pharma leaders. Instead, all three of these companies have elected to own 100% of the rights to their lead molecules. While the median expense for a phase 3 trial is $19 million, the numbers can vary dramatically, depending on how large the patient population is. I'd be nervous if a biotech had less than $100 million in cash (each of these has more). There's no question this independent approach is riskier, but also potentially a lot more rewarding.\nBiotech investors often like to see collaboration with Big Pharma -- it's a validation of the science, and it removes a lot of financial worries for small companies. But if you're chasing big rewards, you might want to look at biotech companies that are still independent (and have enough cash to stay that way).\nCan Pieris pull off a miracle run in 2022?\nPieris stock is very cheap right now, with a $291 million valuation. (You know a stock is cheap when it could have a 10-bagger and still qualify as a small-cap!) Is the stock so cheap because its science is bad?\nIt would probably be more accurate to say that Pieris' science is unproven. Like many unprofitable biotechs, Pieris doesn't have a drug in phase 3 trials yet. In fact, we're still waiting on positive phase 2 data. So it's early, and that's a danger sign. The reason Axsome, Novavax, and Cassava all skyrocketed is that all three companies made the journey from unproven drug to pivotal trials very quickly. Pieris is a few years away.\nAnother major difference is that Pieris has signed multiple collaborative deals -- with Roche, AstraZeneca, and Seagen, among others. In one sense that's good news, because it means that money for clinical trials isn't an issue for the company. Any drugs that work will make it to phase 3 trials and beyond. And all this collaboration adds confidence that the company is on the right track.\nIs Pieris sacrificing its future to pay for its present? In my opinion, no. While AstraZeneca now has rights to the company's asthma drug (its lead molecule), what makes Pieris such an exciting stock is not one particular drug, but the company's entire platform. Pieris owns the rights to all the Anticalin proteins, and its library contains more than 100 billion of these new molecules. Anticalins are much smaller than antibodies, and as such can go where antibodies cannot. AstraZeneca paid big bucks for the rights to Pieris' asthma drug because that Anticalin molecule is small enough to go directly to the lung.\nI love the risk/reward equation for Pieris. If the company's drugs actually work -- we'll have data in that regard next year -- the stock will shoot much higher. Under its existing collaboration agreements, Pieris might make up to $9 billion if its Anticalin drugs reach certain milestones. But what will really make the stock take off is if/when other pharmaceutical players start making deals to add some of the company's Anticalin molecules to their pipelines.\nHow do you value an entire new class of pharmaceuticals? Well, in 2019, worldwide sales for monoclonal antibodies (mAbs) totaled $163 billion. If Pieris' partners report any positive data on its Anticalin drugs next year, the upside for this stock is enormous.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835470370,"gmtCreate":1629735942190,"gmtModify":1633682812558,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Please help to like","listText":"Please help to like","text":"Please help to like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/835470370","repostId":"1198789813","repostType":4,"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163809865,"gmtCreate":1623865742157,"gmtModify":1634026753218,"author":{"id":"3582032677933516","authorId":"3582032677933516","name":"wkwkwkwk","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582032677933516","idStr":"3582032677933516"},"themes":[],"htmlText":"Can be online store","listText":"Can be online store","text":"Can be online store","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163809865","repostId":"2143792622","repostType":4,"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}